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Abstract 
Cancer is currently the second leading cause of death in the United States. 
Although many treatment options exist, some of the most common, including 
radiotherapy and chemotherapy, are restricted by dose-limiting toxicities. In addition, the 
largest hurdle for translating novel biological therapies such as siRNA into the clinic is 
lack of an efficient delivery mechanism to get the therapeutic into malignant cells. This 
work aims to improve this situation by engineering a minimally invasive controlled 
release system that specifically delivers therapeutics to the site of malignant tissue. This 
platform consists of two novel material components: a thermally responsive poly[N-
isopropylacrylamide-co-acrylamide] (NIPAAm-co-AAm) hydrogel and gold-silica 
nanoshells. Therapeutic molecules are encapsulated within a poly(NIPAAm-co-AAm) 
hydrogel carrier, leading to increased serum stability, circulation time, and decreased 
exposure to off-site tissues. Additionally, gold-silica nanoshells embedded within this 
hydrogel will be used to optically trigger therapeutic release from the carrier. This 
hydrogel-nanoshell composite material was designed to be swollen under physiologic 
conditions (37 oC), and expel large amounts of water and absorbed molecules at higher 
temperatures (40-45 oC). This phase transition can be optically triggered by embedded 
gold-silica nanoshells, which rapidly transfer near-infrared (NIR) light energy into heat 
due to the surface plasmon resonance phenomena. NIR light can deeply penetrate 
biological tissue with little attenuation or damage to tissue, and upon exposure to such 
light a rapid temperature increase, hydrogel collapse, and drug expulsion will occur. 
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Ultimately, these drug-loaded hydrogel-nanoshell composite particles would be injected 
intravenously, passively accumulate in tumor tissue due to the enhanced permeability and 
retention (EPR) effect, and then can be externally triggered to release their therapeutic 
payload by exposure to an external NIR laser. This dissertation describes the synthesis, 
characterization, and validation of such a controlled therapeutic delivery platform. 
Initial validation of poly(NIPAAm-co-AAm)-gold nanoshell composites to act as 
a material in site-specific cancer therapeutic delivery was accomplished using bulk 
hydrogel-nanoparticle composite disks. The composite material underwent a phase 
transition from a hydrated to a collapsed state following exposure to NIR light, indicating 
the ability of the NIR absorption by the nanoshells to sufficiently drive this transition. 
The composite material was loaded with either doxorubicin or a DNA duplex (a model 
nucleic acid therapeutic), two cancer therapeutics with differing physical and chemical 
properties. Release of both therapeutics was dramatically enhanced by NIR light 
exposure, causing 2–5 fold increase in drug release. Drug delivery profiles were 
influenced by both the molecular size of the drug as well as its chemical properties.  
Towards translation of this material into in vivo applications, the hydrogel-
nanoshell composite material was synthesized as injectable-sized particles. Such particles 
retained the same thermal properties as the bulk material, collapsing in size from ~330 
nm to ~270 nm upon NIR exposure. Furthermore, these particles were loaded with the 
chemotherapeutic doxorubicin and NIR exposure triggered a burst release of the drug 
payload over only 3 min. In vitro, this platform provided increased delivery of 
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doxorubicin to colon carcinoma cells compared to free-drug controls, indicating the 
irradiated nanoshells may increase cell membrane permeability and increase cellular 
uptake of the drug.  This phenomena was further explored to enhance cellular uptake of 
siRNA, a large anionic therapeutic which cannot diffuse into cells easily.  
This work advances the development of an injectable, optically-triggered delivery 
platform. With continued optimization and in vivo validation, this approach may offer an 
novel treatment option for cancer management.  
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1. Introduction 
Cancer, a group of diseases characterized by the growth and spread of abnormal cells, 
remains a considerable health concern today. In 2010, cancer was the second leading 
cause of death in the United States following heart diseases, accounting for 
approximately 1500 deaths/day; almost 1 in 4 deaths in the U.S. can be attributed to 
cancer (American Cancer Society, 2010). In addition, over the past 15+ years, the death 
rate due to heart disease rate has decreased by 40%, while the cancer death rate has 
stayed more constant with only an 18% decrease, as seen in Figure 1.1.  
 
Figure 1.1. U.S. mortality rates for several diseases in 1991 and 2007. Information age 
adjusted to 2000 U.S. standard population. From (American Cancer Society, 2010). 
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Furthermore, the cost of cancer, including both direct medical costs and indirect mortality 
costs, was estimated to be $263.8 billion in 2010 (American Cancer Society, 2010).  
These statistics indicate that advances in cancer treatments are still needed in order to 
better manage this disease. The research presented in this dissertation aims to improve 
cancer treatment by utilizing a novel platform to better control the delivery of cancer 
therapeutics. 
1.1. Characteristics of Cancer 
Cancer is widely recognized to be a disease involving dynamic changes in the 
genome. It occurs in a wide variety of cell types and tissues, but is universally 
characterized by changes that allow for unregulated cell cycle progression, growth, and 
invasion. Tumorigenesis is a multistep process in which each step reflects genetic 
alterations that drive a progressive transformation of normal cells into highly malignant 
derivatives (Hanahan and Weinberg, 2000). In a 2000 review, Hanahan and Weinburg 
assert that this transformation into a malignant state manifests in six essential alterations 
in cell physiology: (1) self-sufficiency in growth signals, (2) insensitivity to growth-
inhibitory (anti-growth) signals, (3) limitless replicative potential, (4) evasion of 
programmed cell death (apoptosis), (5) sustained angiogenesis, and (6) tissue invasion 
and metastasis (Hanahan and Weinberg, 2000). The authors note that these capabilities 
are shared in common by most, if not all types of human tumors.  
Over the past 10 years, progress in cancer research has led to new observations 
that serve to both clarify and modify the original six hallmarks. In response, Hanahan and 
Weinburg wrote another review in 2011, in which four new concepts were discussed 
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(Hanahan and Weinberg, 2011). Two of these new concepts, (1) genome instability and 
mutation and (2) tumor-promoting inflammation, are thought be critical to the scope and 
conceptualization of the original six hallmarks. In addition, two new, unique hallmarks 
were recognized: (1) reprogramming of energy metabolism and (2) evading immune 
destruction. These hallmarks, along with specific therapeutic approaches to disrupt each 
hallmark, are illustrated in Figure 1.2.  
 
Figure 1.2. Therapeutic targeting of the ten hallmarks of cancer. Drugs that interfere 
with each acquired capability of cancer cells listed are either in clinical trials or approved 
for clinical use in certain forms of cancer. From (Hanahan and Weinberg, 2011). 
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1.2. Motivation: Current Standard of Care 
Conventional cancer treatments include surgery, radiation therapy, and 
chemotherapy. These treatments may be used alone, but are also often used in 
combination. The goal of each treatment option is to kill as much malignant tissue as 
possible while minimizing harm to surrounding healthy tissues.  
Surgical therapy provides the physical removal (resection) of the tumor mass 
(McKinnell, 2006). This is often the most effective treatment for localized disease. It is 
common for adjacent, healthy tissue and associated lymph nodes to be resected during 
surgery to help the pathologist determine if the tumor is invading surrounding tissue and 
decrease the risk of recurrence or metastasis. However, surgery is not applicable for 
tumors in inaccessible anatomic locations or with extensive intermingling of tumor and 
critical normal tissues (McKinnell, 2006).  
In radiation therapy, tumor cells are exposed to ionizing radiation resulting in 
DNA damage, which leads to cell death when the cells try to divide. Therefore, this 
therapy is most toxic to highly proliferative cells, including cancer cells. However, since 
both malignant cells and healthy tissue use the same mechanism for cell division, 
radiation therapy also kills the rapidly dividing cells within renewing tissues such as hair 
follicles, oral-gastrointestinal epithelium, and hematopoietic tissue. Although radiation 
therapy is usually focused to minimize these, these off-site toxicities, along with other 
chronic toxicities, ultimately determine the maximum dose a patient may receive of 
radiation in his or her lifetime (McKinnell, 2006).  
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Chemotherapy is defined as the use of drugs to treat or control cancer. These 
drugs are usually given systemically and aim to target highly proliferative cells. These 
types of drugs include alkylating agents, antimetabolites, natural or semisynthetic 
products, and hormones or hormone inhibitors (Rubin and Williams, 2001). The drugs 
are generally cell cycle phase-specific, as demonstrated in Figure 1.3, and thereby target 
highly proliferative cells to a greater degree than more dormant tissues (Seiwert et al., 
2007). Like radiation therapy, off-site toxicities of chemotherapeutics are significant in 
tissues that are normally in a highly proliferative state, such as the bone marrow, 
gastrointestinal tract, and hair follicles (Rubin and Williams, 2001). This leads to the side 
effects that most people associate with chemotherapy regimens: immunosuppression, 
nausea, and alopecia.  
 
Figure 1.3. Cell cycle schematic and respective sensitivity to chemotherapeutic 
agents. Most agents are active in the S and M phases of the cell cycle and thereby target 
more proliferative tissues to a higher degree than more dormant tissues. Adapted from 
(Seiwert et al., 2007). 
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In addition, many chemotherapeutics also have less common toxic reactions, 
including pulmonary fibrosis (seen with bleomycin, buslfan, and mitocycin C) and 
cardiotoxicity (seen with doxorubicin, daunomycin, mitoxantrone, and idarubicin) (Rubin 
and Williams, 2001). These severe toxicities often lead to restrictions in the total doses of 
these drugs that may be administered (Rubin and Williams, 2001). If a patient 
experiences these toxicities, treatment often has to be ceased immediately, even if the 
drug is effective against the malignant cells. These drugs would benefit from 
administration in a manner that minimizes drug exposure to healthy tissues associated 
with these toxic effects. A more detailed explanation of such controlled delivery manners 
can be found in Section 1.4. 
1.2.1. Emerging Therapy: siRNA 
In recent years, advancing technologies in molecular biology have demonstrated 
that small segments of RNA can be used as a genetics-based cancer therapy. In RNA 
interference, double stranded RNA (dsRNA) hinders the expression of a target gene as a 
result of sequence homology (Oh and Park, 2009). This process occurs naturally in 
mammalian cells, where the enzyme Dicer initiates RNA silencing by breaking down 
long dsRNA molecules into small interfering RNA (siRNA) segments of around 21-23 
nucleotides (Oh and Park, 2009). The siRNA molecules go on to bind to complementary 
sequences in cytosolic mRNA transcripts, thereby preventing protein translation of the 
binding targets. The overall process of RNA interference is summarized in Figure 1.4 
(Bumcrot et al., 2006).  
 7 
 
Figure 1.4. Cellular mechanisms of RNA interference. First, dsDNA is cleaved by 
Dicer into siRNA. These siRNAs are then incorporated into the RNA-induced silencing 
complex (RISC), where the strands are separated. The RISC complex containing the 
antisense strand seeks out and binds to complementary mRNA sequences. These mRNAs 
are then cleaved by the enzyme argonaute, thereby causing mRNA degradation and 
prevention protein translation. From (Bumcrot et al., 2006). 
This biological mechanism can be exploited for cancer therapy by the 
introduction of synthetic siRNA targeted to a gene of choice. Elbashir et al. first showed 
that the introduction of a 21-nucleotide artificial siRNA could trigger gene silencing in 
mammalian cells (Elbashir et al., 2001). This proof of concept study demonstrated the 
downregulation of several different genes coding for various different firefly luciferases 
(Elbashir et al., 2001). Since then, siRNA has been used to downregulate key proteins in 
the progression of cancer showing great therapeutic potential. In fact, several siRNA 
molecules have advanced all the way to clinical trials (Oh and Park, 2009). Furthermore, 
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siRNA has been investigated for use in the treatment of many cancers including breast, 
ovary, cervix, liver, lung, and prostate. (Oh and Park, 2009). 
Therapy using siRNA has several advantages over more traditional therapeutic 
strategies. First, siRNA interferes with translation, not with DNA transcription as seen in 
DNA-based gene therapy approaches. This approach therefore minimizes concerns about 
possible adverse gene alterations (Oh and Park, 2009). Another advantage is that siRNA 
can act on a wide range of protein targets, whereas traditional chemical drugs are limited 
to acting on certain classes of receptors, ion channels, and enzymes. Current biological 
therapies, including monoclonal antibodies and cytokines, mainly target moieties on the 
cell surface. SiRNAs, however, can target any mRNA regardless of the cellular location 
of the translated protein (Oh and Park, 2009).  
A major challenge in the translation of siRNA therapy to the clinic is the efficient 
delivery of the molecule into target cells (Oh and Park, 2009). RNA is relatively large, 
anionic and hydrophilic, and therefore cannot effectively enter cells by passive diffusion. 
In addition, RNA molecules injected intravenously are quickly degraded by serum 
nuclease enzymes and cleared rapidly through the kidneys (Bumcrot et al., 2006). 
Furthermore, these molecules have limited penetration across capillary endothelium and 
inefficient uptake by parenchymal cells (Bumcrot et al., 2006). Therefore, development 
of an in vivo delivery system for siRNA is paramount for an efficient therapeutic effect to 
take place (Oh and Park, 2009). 
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1.3.   Therapeutic Delivery to Solid Tumors 
As mentioned in Section 1.1, one of the hallmarks of cancer is sustained 
angiogenesis. For a solid tumor to grow beyond 2-3 mm, it must recruit its own blood 
supply in order to transport nutrients and O2 to its rapidly proliferating cells (Folkman, 
1971). However, the tumor vasculature that forms differs both structurally and 
functionally from normal vasculature (Jain, 2005).  Tumor vasculature is highly 
disorganized, consisting of tortuous vessels with uneven diameters (Carmeliet and Jain, 
2000). Additionally, these vessels may lack functional pericytes (Benjamin et al., 1999), 
and have been observed to have gaps between endothelial cells as large as 2 µm 
(Hashizume et al., 2000), leading to vessels being highly “leaky”. These phenotypic 
differences are hypothesized to be due to a disruption in the balance between “pro-
angiogenic” and “anti-angiogenic” factors (Carmeliet and Jain, 2000, Jain, 2005). In the 
development of normal vasculature, “pro-angiogenic” factors that promote vessel 
formation (such as VEGF and Ang1) are balanced with “anti-angiogenic” factors that 
restrict vascularization (such as Ang2), leading to the formation of a highly organized, 
hierarchical vessel structure (Carmeliet and Jain, 2000). However, in tumor angiogenesis, 
there is a tip in the balance towards the “pro-angiogenic” side, leading to rapid growth of 
a disorganized vascular network (Carmeliet and Jain, 2000). These differences in 
vasculature are summarized in Figure 1.5.  
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Figure 1.5. Differences in normal vs. tumor vasculature. [A] Normal vasculature (left) 
is highly organized in a distinct hierarchal structure, whereas tumor vasculature (right) is 
disorganized and erratic. [B] Representative images of normal vasculature (skeletal 
muscle, left) and tumor vasculature (colon carcinoma, right). [C] The formation of these 
vessel phenotypes are hypothesized to be due to the balance between pro- and anti- 
angiogenic factors, where in the case of tumor vasculature formation this balance tips 
towards the “pro-angiogenic” side. Adapted from (Jain, 2005). 
In tumor vasculature, particles ranging in size from 10-500 nm have been shown 
to pass through the gaps between endothelial cells and extravasate out of the vessel 
(Maeda et al., 2000, Cuenca et al., 2006). Additionally, tumors often do not have the 
functional lymphatic vessels that are seen in normal tissues (Jain, 1987), leading to these 
extravasated particles persisting in the tumor interstitium. This phenomena, first observed 
by Matsumura and Maeda in 1986, is known as the “Enhanced Permeability and 
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Retention” (EPR) effect (Matsumura and Maeda, 1986), and is often exploited for 
delivery of nanoparticle platforms to solid tumors (Maeda et al., 2000). 
It is important to note that the leaky vasculature and lack of functional lymphatics 
in solid tumors leads to an increase in interstitial pressure towards the center of the tumor 
(Baxter and Jain, 1989). This causes a convective barrier for delivering therapeutics to 
the center of the tumor and leads to diffusion being the main mode of transport of 
molecules at the center of the tumor (Jain, 1990, Baxter and Jain, 1989). 
1.4.  Controlled Delivery Methods 
Therapeutic efficacy of both chemotherapeutics and biological therapeutics (such 
as siRNA) would benefit from administration in a controlled delivery manner. Controlled 
delivery systems can influence the performance of a therapeutic agent by manipulation of 
its effective concentration, location, and duration (Park, 1997). Drug delivery via 
controlled release offers several advantages to improve cancer therapy including (1) 
localized delivery of the drug to a particular tissue, thereby lowering the systemic drug 
level, (2) preservation of drugs that are rapidly destroyed by the body, (3) reduced need 
for follow up care, (4) increased comfort, and (5) improved compliance (Langer, 1990).  
The field of controlled drug release has grown from the 1940s, when sustained 
release products aiming to reduce the frequency of dosing first came on the market, to 
present day, where much focus is on delivery of a variety of molecules including genes, 
proteins, and other therapeutics by a wide range of self-regulating systems (Park, 1997).  
In fact, in a review dating back to 1981, Langer and Peppas noted that while synthesis 
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and discovery of new potent drugs is important, critical attention should also be given to 
the manner in which these drugs are delivered (Langer and Peppas, 1981).  
Typically, these systems are designed to release therapeutics at a desired 
anatomical site and maintain drug concentrations within a therapeutic band for a desired 
duration, as illustrated in Figure 1.6 (Liechty et al., 2010). Such systems may be diffusion 
controlled, swelling controlled (due to osmosis), chemically controlled (due to material 
degradation) or externally-triggered by a stimulus such as changes in temperature or pH 
(Liechty et al., 2010). Polymeric materials have been developed for all four of these types 
of delivery schemes.  
 
Figure 1.6. Profiles of controlled release, burst release, and pulsatile release systems 
within a therapeutic band. Adapted from (Liechty et al., 2010). 
There are some controlled delivery systems for chemotherapeutics on the market 
today, most notably Doxil®, which is a poly(ethylene glycol) [PEGylated] liposome 
containing the chemotherapeutic doxorubicin (Safra et al., 2000). This formulation 
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increases the serum half-life of the drug, thereby allowing a higher percentage of the 
administered dose to reach the tumor site (Safra et al., 2000). However, Doxil® is given 
systemically and some drug will leak out of the liposome over time, leading to off-site 
toxicity.  
Another example of a controlled delivery system for chemotherapeutics that is on 
the market is bis-chloronitrosourea (BCNU) wafers (Gliadel®) for the management of 
brain malignancies. This chemically-controlled delivery platform consists of 
poly(anhydride)-based wafers and are loaded with the chemotherapeutic carmustine. 
These poly(anhydride) wafers are implanted directly into the brain following surgical 
tumor resection, and slowly hydrolytically degrade, releasing drug over time to reduce 
the likelihood of recurrence (Westphal et al., 2003). However, surgical access is 
necessary for implantation, making this strategy not applicable for all cancer sites. A non-
invasive drug delivery system that triggers drug release to only occur at the tumor site 
would be advantageous over these existing drug delivery systems.  
1.5. Conclusions and Design Rationale 
This work aims to create an externally-triggered drug delivery platform for the 
delivery of various cancer therapeutics, ranging from small molecules to large biologics. 
This platform will be designed to provide a burst delivery of a chemotherapeutic only at 
the site of malignant tissue. The platform will be comprised of two novel material 
components: gold-silica nanoshells and a thermally-responsive poly(N-
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isopropylacrylamide-co-acrylamide) (NIPAAm-co-AAm) polymer coating, summarized 
in Figure 1.7.  
 
Figure 1.7.  Summary of material components for developing an injectable, 
optically-triggered drug delivery platform. 
The polymer coating will contain drug, allowing the drug-filled particles to 
circulate throughout the body without the drug acting on tissue. Drug release from this 
coating will be triggered by temperature increases, which in turn can be triggered by 
exploiting the optical properties of the gold-silica nanoshell.  
Nanoparticle platforms offer promising approaches for cancer therapy due to 
unique material properties that are seen at the nanoscale. In particular, the size and optical 
properties of gold-silica nanoshells have been utilized for photothermal therapy, which is 
significantly less invasive than traditional therapies such as surgery. Additionally, unlike 
most chemotherapeutic and radiation therapy approaches, the location of the therapy 
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(heating) is tightly controlled to occur only where nanoshell and a near-infrared (NIR) 
laser application are combined. 
Stimuli-responsive materials have been widely studied in the context of controlled 
drug delivery (Qiu and Park, 2001). In particular, thermally-responsive hydrogels can be 
used to encapsulate a drug payload in their swollen state, and then triggered to collapse 
and expel water and absorbed molecules upon a temperature increase. By combining such 
a material with the above mentioned NIR absorbing nanoparticles to locally generate heat 
in response to light, extremely tight spatial and temporal control over material transition 
and drug release can be achieved. A more detailed background on gold nanoparticles and 
stimuli-responsive materials follows in Chapter 2.  
This dissertation builds on successful results from previous studies of thermally-
responsive hydrogel-nanoparticle composites to create an optically-controlled drug 
delivery platform. This injectable, controlled delivery platform consists of a drug-
containing, thermally-responsive hydrogel coating on individual gold-silica nanoshells. 
These particles can be injected intravenously and passively accumulate in tumor tissue 
due to the EPR effect. Once the particles reach the tumor site, an NIR laser will be 
applied to the tumor. This will cause a rapid heating of the embedded nanoshells, which 
in turn triggers a collapse of the polymer coating and release of absorbed drug molecule 
directly at the tumor site.  
In the next chapter, the methods to synthesize and characterize the gold-silica 
nanoshells used throughout this dissertation, as well as the synthesis and characterization 
of bulk poly(NIPAAm-co-AAm)-gold nanoshell composites used for initial validation 
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studies are described. Chapter 3 discusses the ability to load and release a range of cancer 
therapeutics from this material as well as validation of the system in vitro against a colon 
carcinoma cell line.  Chapters 4-6 discuss synthesis of this composite material as 
injectable-sized particles using two different techniques. In Chapter 4, a templating 
method using a gelatin mold is used for particle synthesis, while Chapter 5 describes 
particle synthesis using controlled radical polymerization using surface initiated-atom 
transfer radical polymerization (SI-ATRP). Chapter 6 analyzes the ability to load and 
release drug from the SI-ATRP synthesized particles, as well as validation of the system 
in vitro. Chapter 7 investigates the ability of NIR irradiation of gold-silica nanoshells to 
induce cell membrane permeability, and exploits this mechanism for delivery of large 
biologic therapeutics (siRNA).  Finally, concluding remarks are found in Chapter 8 along 
with recommendations for future studies.  
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2. Material Synthesis and Characterization1 
The delivery platform developed in this dissertation consists of two material 
components: near-infrared absorbing gold-silica nanoshells and a thermally-responsive 
poly(NIPAAm-co-AAm)-hydrogel coating. The first portion of this chapter describes the 
properties of these two materials and discusses previous studies that have utilized these 
materials in cancer medicine. Additionally, the methods for the synthesis and the 
characterization of gold-silica nanoshells, bulk poly(NIPAAm-co-AAm) hydrogels, and 
bulk nanoshell-hydrogel composites are described herein. The gold-silica nanoshells 
described are used in all later chapters, and the bulk hydrogels and composites are also 
used in Chapter 3.   
2.1. Gold Nanoparticles 
Metal nanoparticles have been highly investigated for use in biological and 
medical applications due to their unique size and optical properties. In particular, gold-
based nanoparticles provide a biocompatible surface layer, and well-established gold-
thiol chemistries can be easily utilized for a variety of surface functionalizations. The 
four main gold nanoparticle types that will be further discussed are solid gold 
                                                
 
1 Portions of this chapter are adapted from: 
 
Strong L.E., and West J.L. “Thermally Responsive Polymer-Nanoparticle Composites for Biomedical 
Applications.” Wiley Interdiscip Rev Nanomed Nanobiotechnol. 3(3): 307-317 (2011). 
 
Strong L.E., Dahotre S.N, and West, J.L. Hydrogel-nanoparticle composites for optically modulated cancer 
therapeutic delivery. J. Control. Release. 178(8): 63-68 (2014).  
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nanoparticles (AuNPs), gold nanorods (AuNRs), gold-gold sulfide (Au-Au2S) 
nanoparticles, and gold-silica nanoshells, although a wide variety of shapes and 
formulations have been reported. These particles are of importance in biomedical 
applications because of their strong and tunable optical properties, which can be 
exploited to induce localized heating upon exposure to light. Additional properties of 
these particles are summarized in Table 2.1. 
Table 2.1. Nanoparticle Properties. Adapted from (Strong and West, 2011). 
 
2.1.1. Optical Properties 
The unique optical properties of gold nanoparticles have been investigated for 
many years, dating back to Michael Faraday’s observation that gold colloids interact with 
light to produce a vibrant red color (Faraday, 1857). When these particles are exposed to 
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electromagnetic waves, the particles are set into motion by the electric field. If the 
frequency of incident light equals the natural frequency of the free vibrations in the 
particle, resonance occurs which is typically accompanied by a large amount of 
absorption.  
2.1.1.1. Optical Absorption  
The absorptive processes of gold-based nanoparticles are due to the surface plasmon 
resonance phenomena, in which exposure of an electric field of light at a particle’s peak 
extinction (resonance condition) induces a coordinated oscillation of conduction band 
electrons (Figure 2.1), and this absorbed energy may be eventually dissipated as thermal 
energy, causing localized heating (Kelly et al., 2002). In addition to absorption, scattering 
of light may occur at frequencies not corresponding to the natural frequencies of the 
particle, and is discussed in more detail in the following section.  
 
 
Figure 2.1. Diagram of surface plasmon resonance. Upon light irradiation, the electric 
field causes the conduction electron charge cloud to oscillate relative to the particle 
nuclei. From (Kelly et al., 2002). 
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2.1.1.2. Optical Scattering 
In 1908, Mie theory was developed to describe the scattering properties of gold 
nanoparticles by solving Maxwell’s equations of light scattering by gold colloids 
spherical or cylindrical shape, and was further modified to describe core/shell 
nanoparticles in 1951 (Aden and Kerker, 1951).  
Mie theory may be used to describe the dependence of geometry on particle 
resonance for particles consisting with a dielectric core and gold shell (Averitt et al., 
1999a). Assuming the total particle size is smaller than the wavelength of incident light 
(r2<<λ), a quasi-static approximation can be used, which assumes spatial variations in the 
incident electromagnetic field are unchanging but still time dependent.  Additionally, the 
particles are assumed to be perfectly spherical and any dipole-dipole interactions between 
adjacent particles are ignored as the particles are at a dilute concentration in solution.  
These equations are solved using the dielectric constants of the core (ε1), shell (ε2) and 
dispersive medium (ε3), as well as the core radius (r1) and total particle radius (r2), as seen 
in Figure 2.2. 
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Figure 2.2. Nanoshell geometry used in Mie Theory calculations. Particles consist of a 
core radius (r1) and total particle radius (r2). The dielectric constants of the dispersive 
media, shell, and core are ε3, ε2, and ε1 respectively. 
The following equations, first described by Averitt et al., are important for 
describing the polarization behavior of conduction band electrons in the gold shell in 
response to light. First, Equation 2.1 describes the ratio of particle volume to shell 
volume (P): 
𝑃 = 1− 𝑟!𝑟! !   Equation 2.1  
 Next, εa and εb are defined using the particle volume ratio as well as the dielectric 
constants of the various mediums: 𝜀! = 𝜀! 3− 2𝑃 + 2𝜀!𝑃   Equation 2.2  
 𝜀! = 𝜀!𝑃 + 𝜀! 3− 𝑃    Equation 2.3  
 
With these values of εa and εb, the polarizability (α) of the particles can be 
described. This described the degree with which electrons in the outer shell are displaced 
from the particle mass in response to electromagnetic irradiation: 
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𝛼 = 4𝜋𝜀!𝑟!! 𝜀!𝜀! − 𝜀!𝜀!𝜀!𝜀! + 2𝜀!𝜀!    Equation 2.4   
where ε0 is the permittivity of free space (8.85.10-12 F/m). The resonance condition of a 
particle is obtained when the polarization (α) is maximal, and thus occurs as the real 
portion of the denominator in Equation 2.4 reaches 0. Assuming both the core and 
dispersive media are dielectric, i.e. Im(ε1,ε3) = 0, a resonance condition as a function of 
wavelength can be obtained:  𝑟!𝑟! = 1+ 32 𝜀!′ 𝜆 𝜀! + 2𝜀!𝜀!′ 𝜆 ! − 𝜀!′ 𝜆 𝜀! + 𝜀! + 𝜀!𝜀! − 𝜀!′′ 𝜆 ! ! !   Equation 2.5   
 
Thus, Equation 2.5 provides an expression relating the core radius: particle radius 
ratio needed to obtain a resonance condition at a particular wavelength. In fact, by 
adjusting r1/r2 from 0.6 to 0.9, the plasmon resonance of a particle shifts from 600 nm to 
over 1000 nm. These equations were originally developed to describe gold-gold sulfide 
nanoparticles (Averitt et al., 1999a), but may also be used to describe gold-silica 
nanoshells (Oldenburg et al., 1998). Figure 2.3 shows the optical tunability of gold-silica 
nanoshells using these parameters. Particles with a 120 nm silica core can be designed to 
have a peak extinction coefficient from near 700 nm to over 1000 nm by decreasing the 
shell thickness from 20 nm to 5 nm (Hirsch et al., 2006). 
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Figure 2.3. Optical tunability of gold-silica nanoshells. By altering gold-silica 
shell:core ratios, optical tunability can be obtained. A thinner shell causes a red shift in 
absorbance. Adapted from (Hirsch et al., 2006). 
2.1.1.3. Optical Properties of Biological Tissue 
In biological tissues, light absorption is mainly due to either water molecules or 
macromolecules such as proteins and pigments (Niemz, 2004). Water, the main 
constituent in most tissues, has a very small absorption coefficient in the visible range, 
but its absorption coefficient increases drastically starting at around 900 nm. In 
vascularized tissues, hemoglobin is the predominant macromolecule absorber, and has 
absorption peaks in the UV and visible spectrum, but its absorption drops off 
significantly around 650 nm.  
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Thus, the near-infrared (NIR) range (700-900 nm) is above the absorption of 
biological molecules such as hemoglobin (<650 nm) and below the range absorbed by 
water (>900 nm), as illustrated in Figure 2.3 (Weissleder, 2001).  
 
Figure 2.4. Tissue permeability of NIR light. Near-infrared light (650-900 nm) is of 
particular interest in biological applications as it is minimally absorbed by biological 
chromophores and water. From (Weissleder, 2001). 
Therefore, these wavelengths may deeply penetrate biological tissue with relatively 
little attenuation or tissue damage. Gold-based nanoparticles including gold-gold sulfide 
nanoparticles, gold-silica nanoshells, and gold nanorods can all be tuned to have a peak 
extinction in the NIR range (Averitt et al., 1999b, Averitt et al., 1997, Hirsch et al., 2006, 
Yu et al., 1997). 
2.1.2. Types of Gold Nanoparticles  
Gold nanoparticles (AuNPs, also called gold colloids) are one of the most stable 
and highly investigated metal nanoparticle (Daniel and Astruc, 2004).  These particles, 
thought of as “soluble gold” in antiquity, were used for aesthetic and curative purposes as 
early as the 4th and 5th centuries B.C. (Daniel and Astruc, 2004). Several synthesis 
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techniques exist, the most common being citrate reduction of chloroauric acid (HAuCl4) 
in water (Turkevich et al., 1951). These particles (with diameters ranging from 2-100 nm) 
have maximum absorption around 520-575 nm, depending on the diameter of the 
particles, with the smaller particles maximally absorbing at lower wavelengths (Daniel 
and Astruc, 2004).  
2.1.2.1. Gold Nanorods  
Gold nanorods are anisotropic nanoparticles composed of solid gold, where 
particle shape strongly influences optical properties. Gold nanorods show a surface 
plasmon band near 520 nm similar to spherical AuNPs, but also have a second band at a 
longer wavelength (Mohamed et al., 1998). These optical properties are dependent on the 
particle’s aspect ratio (ratio of length to diameter) (Yu et al., 1997). The dominant surface 
plasmon band occurs at a longer wavelength, and is based on the axial length of the 
particle (Yu et al., 1997). The secondary surface plasmon band occurs around 520 nm 
due to the weaker transverse resonance (Yu et al., 1997). Particles with larger aspect 
ratios will have the primary longitudinal resonance at a longer wavelength than particles 
with a smaller aspect ratio (Yu et al., 1997). These particles can be synthesized either by 
use of rigid templates or, more commonly, by use of seed and growth solutions in the 
presence of surfactants (Nikoobakht and El-Sayed, 2003). 
2.1.2.2. Gold-Gold Sulfide Nanoparticles 
Gold-gold sulfide nanoparticles were first developed by Zhou et al. (Zhou et al., 
1994). Due to their optical properties, these particles were originally thought to consist of 
a dielectric gold sulfide (Au2S) core surrounded by a thin gold shell (Averitt et al., 1997).  
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Controversy still remains over the exact structure of these particles; however optical 
simulations using Mie theory and surface conjugation studies suggest particles have a 
core/shell structure with a continuous gold coating (Averitt et al., 1999a, Gobin et al., 
2010). These nanoparticles are synthesized by mixing a sulfur-based precursor (Na2S or 
Na2S2O3) with an excess of HAuCl4 (Zhou et al., 1994, Averitt et al., 1997).  The ratios 
of these two materials can be adjusted to alter surface plasmon resonance of the particles 
from 600 nm to greater than 1000 nm (Averitt et al., 1999a). Much research has been 
done on gold-gold sulfide nanoparticles that are NIR absorbing; these particles generally 
have a 35-55 nm diameter and surface plasmon resonance near 800-900 nm (Averitt et 
al., 1999a, Averitt et al., 1999b, Sershen et al., 2000, Gobin et al., 2010, Day et al., 2010).  
2.1.2.3. Gold-Silica Nanoshells 
Gold-silica nanoshells were first developed by Oldenburg et al. (Oldenburg et al., 
1998).  These particles consist of a dielectric silica core surrounded by a solid gold shell, 
and adjustments of these two parameters provides tunability of the optical properties of 
these particles, with thinner gold shells causing a red-shift in extinction spectra. Peak 
extinction coefficients of these gold-silica nanoshells can range from visible to near-
infrared and even infrared ranges (Hirsch et al., 2006). Most photothermal studies have 
utilized particles with a 120 nm core and 10-15 nm shell, as this corresponds to a peak 
absorption coefficient in the near infrared range, where biological tissue is most 
permissive of light (Sershen et al., 2001, Sershen et al., 2002c, Sershen et al., 2005, 
Hirsch et al., 2003, Hirsch et al., 2006, Bikram et al., 2007, Kim and Lee, 2008, Day et 
al., 2009). Gold-silica nanoshells have been widely researched for applications in cancer 
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medicine due to their ease of synthesis and predicable optics, and were therefore chosen 
as the triggering component for the delivery platform developed in this dissertation. 
2.1.3. Gold Nanoparticles in Cancer Medicine 
Near infrared absorbing gold nanoparticles, particularly gold-silica nanoshells, 
have been investigated for both imaging and therapy applications in cancer medicine. 
This is due to numerous advantageous properties of the particles. First, the outer shell of 
these particles is made of reduced gold, a material known to be biocompatible due to its 
resistance of corrosion and low toxicity (Hirsch et al., 2006). Second, the size of these 
particles allows them to be injected intravenously and passively accumulate in tumor 
tissue due to the EPR effect (Matsumura and Maeda, 1986). Finally, the optical extinction 
of nanoshells involves both scattering and absorption components. The scattering 
properties of nanoshells can be harnessed for optical imaging of the particles using dark 
field microscopy, optical coherence tomography (OCT), or reflectance confocal 
microscopy (RCM) (Gobin et al., 2007, Loo et al., 2005, Coughlin et al., 2014). When 
these particles absorb light, the electron-photon interactions within the gold shell yield to 
heat dissipation and results in photothermal ablation of nearby cells (Hirsch et al., 2006). 
Photothermal therapy is advantageous for cancer management as cell death only occurs 
where both nanoshell accumulation and NIR light exposure occurs, minimizing off-site 
toxicity commonly seen in other cancer treatment modalities. A brief discussion of the 
use of gold-silica nanoshells for cancer therapy follows. 
 28 
2.1.3.1. In vitro Studies 
Photothermal therapy using gold-silica nanoshells was first demonstrated by Hirsch 
et al. in 2003 (Hirsch et al., 2003). In this study, SK-BR-3 human breast carcinoma cells 
were incubated with gold-silica nanoshells and exposed to an NIR laser. Cells that were 
incubated with nanoshells exhibited a loss in viability upon NIR exposure, whereas cells 
without nanoshells had no loss in viability (Hirsch et al., 2003).  
 
Figure 2.5. In vitro validation of photothermal therapy. [A] Cells irradiated in the 
absence of nanoshells maintained viability as determined by Calcein AM staining. [B] 
Cells irradiated in the presence of nanoshells showed a circular zone of cell death 
indicated by a lack of Calcein AM staining. Adapted from (Hirsch et al., 2003). 
Further in vitro studies have focused on active targeting of nanoshells using 
antibodies and other protein based ligands including anti-HER2 (Loo et al., 2005, Lowery 
et al., 2006, Bernardi et al., 2008), anti-IL13Rα2 (Bernardi et al., 2008), ephrinA1 (Gobin 
et al., 2008), and VEGF (Day et al., 2012). Gold colloids (Pitsillides et al., 2003), gold-
gold sulfide nanoparticles (Gobin et al., 2010, Day et al., 2010) and gold nanorods 
(Huang et al., 2006) have also been investigated for photothermal therapy potential in 
vitro, displaying similar results as gold-silica nanoparticles.  
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2.1.3.2. In vivo Studies  
Photothermal therapy has been further evaluated in several in vivo studies, most 
commonly in mouse models. In the first study by Hirsch et al., transmissible venereal 
tumor (TVT) cells were inoculated in the hind leg of SCID mice and grown to a diameter 
of ~1 cm (Hirsch et al., 2003). Poly(ethylene glycol) (PEG)-passivated gold silica 
nanoshells were injected interstitially at the tumor site. Nanoshells are often coated with 
polymer chains such as PEG, as this has been shown to minimize plasma protein 
adsorption and therefore increase in vivo circulation time of the particles. Next, tumor 
sites were exposed to 820 nm light at 4 W/cm2, and temperature profiles were obtained 
using phase-sensitive, fast spoiled gradient-echo MRI for thermal imaging. Results 
showed an average temperature increase of 9.1±4.7 oC, and gross pathology indicated 
tissue damage and hemorrhaging. 
Not all tumor sites will be amenable to having direct injection of particles into the 
tumor. Further studies have shown the ability of gold-silica nanoshells to be injected 
intravenously, circulate throughout the body, and passively accumulate in tumor tissue 
via the EPR effect. In the first of such studies by O’Neal et al., PEGylated gold-silica 
nanoshells were injected into the tail vein of mice with a subcutaneous tumor (O'Neal et 
al., 2004). The tumor was exposed to an 808 nm diode laser 6 hours post-injection. In 
addition, a “sham” group received a saline injection followed by laser treatment, and a 
control group received no treatment. Figure 2.6 shows a Kaplan-Meyer survival plot for 
the three groups, with all mice in the nanoshell-assisted photothermal therapy (NAPT) 
group surviving for the 60 day period, whereas the mean survival for the control and 
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sham groups were 10.1 days and 12.5 days respectively. Further in vivo studies have 
investigated NAPT as a potential treatment for malignant glioma (Day et al., 2011, Day 
et al., 2012).   
 
Figure 2.6. Survival curve from NAPT. NAPT mice showed 100% survival after 60 
days, while the sham and control groups had an average survival of 12.5 and 10.1 days 
respectively. From (O'Neal et al., 2004). 
Studies of the biodistribution and clearance of gold-silica nanoshells indicate that 
the particles are primarily cleared via the liver and spleen (James et al., 2007). At 24 
hours post injection, there are higher nanoshell concentrations in the tumor versus most 
other tissues. Eventually these particles are cleared by the reticuloendothelial system 
(RES) primarily through the liver and spleen, and no toxicities or bioincompatibilities 
have been seen up to 404 days post injection (Gad et al., 2012). 
Due to the promise shown in these in vivo studies, photothermal therapy with 
gold-silica nanoshells is currently in FDA clinical trials for refractory head and neck 
cancer as well as primary and metastatic lung cancer (Nanospectra Biosciences, 2014). In 
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this treatment, nanoshells are injected intravenously, allowed to passively accumulate in 
the tumor, and then the tumor site is exposed to NIR light from a fiber optic probe 
(Nanospectra Biosciences, 2014).  
2.1.3.3. Multimodal Particles 
The inherent ability of gold-silica nanoshells to both scatter and absorb light 
allows for a single particle platform to be used for both diagnostic purposes (imaging) 
and therapy (photothermal ablation). These particles have been used for contrast agents 
for a variety of imaging techniques. Gobin et al. demonstrated that gold-silica nanoshells 
can be used for both contrast agents for OCT and photothermal therapy simultaneously 
(Gobin et al., 2007). In addition to their scattering properties, gold-silica nanoshells also 
exhibit two-photon induced photoluminence, allowing utilization of two-photon 
microscopy for analysis of nanoparticle distribution in tumor tissue (Park et al., 2008). 
Additionally, Coughlin et al. endowed gold-silica nanoshells with magnetic properties by 
conjugation of gadolinium chelates, thus creating a single particle platform providing MR 
contrast, optical contrast, and photothermal therapy (Coughlin et al., 2014). 
2.2. Thermally Responsive Polymers 
The gold-silica nanoshells previously described will provide the stimulus for drug 
release from a hydrogel coating. Stimuli-responsive ‘smart’ polymers undergo fast, 
reversible conformational changes in response to small changes in the environment 
(Galaev and Mattiasson, 1999). These changes typically involve the polymer 
microstructure transitioning between a hydrophilic and hydrophobic state, altering chain 
conformations leading to macroscopic material size and properties changes (Galaev and 
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Mattiasson, 1999). Systems responsive to local chemical changes, such as changes in pH, 
as well as systems responsive to external stimuli, such as ultrasound, light, or 
temperature, have been studied (Bikram and West, 2008). Commonly studied 
temperature-sensitive polymers include acrylamide-based hydrogels, especially 
poly(NIPAAm), as well as elastin-like polypeptides (ELPs) (Galaev and Mattiasson, 
1999, Meyer et al., 2001b, Chilkoti et al., 2002, Bikram and West, 2008).  
Many temperature-sensitive polymers display lower critical solution temperature 
(LCST) behavior, in which a reversible volume phase transition occurs. At lower 
temperatures, it is thermodynamically favorable for water molecules to form hydrogen 
bonds with polar groups on the polymer chains, causing the hydrogel to be in a swollen 
state. At higher temperatures, there is an increase in Gibbs free energy (ΔG), and 
hydrogen bonding between the water molecules and polymer chains becomes 
thermodynamically unfavorable compared to polymer-polymer and water-water 
interactions (Schild, 1992). This causes the water to move into bulk solution and the 
polymer chains to collapse onto themselves forming hydrophobic interactions (Sasak et 
al., 1996).   
2.2.1. N-isopropylacrylamide and Other Acrylamides 
Poly(N-isopropylacrylamide) is a widely studied thermally-responsive polymer 
that exhibits an LCST near physiologic temperatures (Bikram and West, 2008). Pure 
poly(NIPAAm) hydrogels have an LCST range of 25-32 oC, and by incorporating a more 
hydrophilic comonomer into the hydrogel, this LCST can be raised to near 45-50 oC 
(Yoshida et al., 1994). Common comonomers used include acrylamide (AAm) or acrylic 
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acid (AAc). In addition, incorporation of N-isopropylmethacrylamide (NIPMAAm) 
increases the LCST as the steric hinderance associated with the additional methyl group 
inhibits the phase transition (Keerl et al., 2008). In contrast, hydrogels consisting of 
hydrophilic acrylamide/acrylic acid monomers exhibit a positive volume change with 
increasing temperatures (Owens et al., 2007a, Owens et al., 2007b). The chemical 
structures of these various acrylamides are described Figure 2.7.   
 
Figure 2.7. Chemical structures of various acrylamides.  
2.2.2. Elastin-Like Polypeptides 
Another widely researched thermally-responsive polymer material is elastin-like 
polypeptides (ELPs), which are synthetic peptides derived the hydrophobic domain of 
tropoelastin (Urry, 1997). ELPs generally consist of oligiomeric repeats of the 
pentapeptide VPGXG (where X is any amino acid except proline) (Urry, 1997). By using 
recombinant methods to synthesize these polymers, a monodisperse product with little 
batch-to-batch variability can be achieved, which is highly advantageous over synthetic 
polymeric materials (Meyer et al., 2001b, Chilkoti et al., 2002, Bikram and West, 2008).  
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By altering amino acid sequence or number of repeats, ELP LCSTs (also commonly 
called transition temperatures, or Tt) are highly tunable and can be brought to above 
physiologic temperatures (Meyer et al., 2001a, Chilkoti et al., 2002, Meyer et al., 2001b). 
ELPs are commonly synthesized by inducing the expression of a genetic sequence that 
encodes these repetitive polypeptides in E. coli and then purifying the peptide product. 
This is commonly done through a process known as recursive directional ligation (RDL), 
which allows the synthesis of large, repetitive genes (Chilkoti et al., 2002). Additionally, 
these materials can be designed such that they can assemble into crosslinked hydrogel 
networks (Asai et al., 2012).  
2.2.3. Thermally-Responsive Polymers in Cancer Medicine  
Many of the first comprehensive studies of a thermally responsive polymer being 
used in cancer medicine studies come from the Chilkoti group (Meyer et al., 2001b, 
Meyer et al., 2001a, Dreher et al., 2003, Furgeson et al., 2006, Liu et al., 2006, Dreher et 
al., 2007, MacKay et al., 2009, Liu et al., 2010). ELP chains may be conjugated to 
hydrophobic chemotherapeutic drugs to drive self-assembly into macromolecule 
complexes. Such complexes improve chemotherapeutic administration by (1) increasing 
the overall accumulation in solid tumors, (2) distributing drug homogenously throughout 
tumor tissues, and (3) increasing intracellular localization of these therapeutics 
(MacEwan et al., 2010). The first of such studies, published in 2001, showed that ELPs 
conjugated to drugs could be thermally targeted to solid tumors (Meyer et al., 2001a). 
ELPs were designed to have a Tt of ~41 oC, such that these particles would remain 
soluble in solutions below their Tt (such as at physiologic temperature), but then become 
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insoluble and aggregate at solution temperatures above 41 oC. These particles were 
injected intravenously and circulated throughout the body at 37 oC. However, if localized 
hyperthermia treatments were used to heat a solid tumor, these particles became insoluble 
and aggregated, resulting in increased tumor accumulation (Meyer et al., 2001a).  Similar 
results have been seen in additional studies (Liu et al., 2006) and additional analysis 
shows that thermal cycling of the tumor between 37oC and 41 oC further enhances ELP 
accumulation (Dreher et al., 2007). 
A similar study compared the ability to target both thermally responsive ELPs and 
thermally responsive poly(NIPAAm-co-AAm) to tumors (Meyer et al., 2001b). In this 
study, both the ELP and poly(NIPAAm-co-AAm) used were tuned to have an LCST at 
40 oC. This was accomplished by substituting Ala and Gly residues for the more 
hydrophobic Val at the fourth position of the ELP pentipeptide, and by using an 84:16 
ratio of NIPAAm:AAm in the poly(NIPAAm-co-AAm). Heating did increase 
accumulation of both thermally responsive carriers in the tumor over both controls; 
however, the ELP displayed enhanced accumulation in tumors over the polymer. The 
authors speculate that this may be because the LCST of poly(NIPAAm) and its 
copolymers can only be tailored to a limited extent by altering incorporation of 
comonomers, chain length, sequence, and stereochemistry; whereas ELPs genetic control 
allows for more precise tuning of chemical properties such as transition temperature 
(Meyer et al., 2001b).  
A study by MacKay et al. analyzed the in vivo efficacy of an ELP-like drug 
carrier loaded with the chemotherapeutic doxorubicin (MacKay et al., 2009).  These 
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carriers, called chimeric polypeptides (CPs), consisted of two segments: a biodegradable 
ELP segment and a short doxorubicin attachment segment. These particles self-assemble 
into sub-100 nm nanoparticles upon drug attachment, as seen in Figure 2.8. Particles were 
injected into a BALB/c subcutaneous mouse tumor model via a tail vein injection (5 mg 
doxorubicin equivalent/kg). After 24 hours post-administration, tumor tissue had a 3.5-
fold increase in doxorubicin concentration for the CP-doxorubicin group compared to the 
free doxorubicin group. In addition, the CP-doxorubicin group showed decreased 
doxorubicin concentration in several tissue sites known to be affected by doxorubicin 
side effects, including the muscle, lung, and heart (MacKay et al., 2009).  
 
Figure 2.8. Self assembly of CP-doxorubicin nanoparticles. [A] After conjugation of 
doxorubicin (red triangles) to chimeric polypeptides (blue lines), these particles self 
assemble into micelles in aqueous environments. [B] These micelles are smaller than 100 
nm, as demonstrated by freeze-fracture TEM (scale bar = 200 nm). Adapted from 
(MacKay et al., 2009). 
It is interesting to note that this study did not utilize the thermal properties of the 
CP particles. A further study investigated a similar CP-doxorubicin material designed to 
transition from nanoscale micelles to microscopic aggregates upon mild hyperthermia 
(39-42 oC), as to allow for thermal targeting (McDaniel et al., 2012). Additional studies 
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have investigated drug conjugation to ELPs through acid-labile hydrazine bonds for drug 
release within the acidic environment of lysosomes (Dreher et al., 2003, Furgeson et al., 
2006), the effect of ELP-radionuclide conjugates on tumor progression (Liu et al., 2010), 
active targeting of complexes to tumor tissue using a CD13 targeting peptide (Simnick et 
al., 2011),  and synthesizing complexes which respond to multiple stimuli (including 
temperature pH, and cosolutes) (Callahan et al., 2012). Additionally, other groups have 
looked at ELPs as delivery vehicles for short peptides to disrupt transcriptional functions 
(Bidwell and Raucher, 2005), and micelle formation by combining poly(NIPAAm)-
chains and the chemotherapeutic 5-fluorouracil (Zhang et al., 2012).   
2.3. Thermally Responsive Polymer-Nanoparticle Composites  
Thermally responsive polymer-metal nanoparticle composites couple the ability 
of certain metal nanoparticles to convert external stimuli to heat with polymers that 
display sharp property changes in response to temperature changes, allowing for external 
control over polymer properties. These systems have been investigated for a variety of 
biomedical applications, including drug delivery (Sershen et al., 2000, Sershen et al., 
2002a, Bikram et al., 2007, Satarkar and Hilt, 2008), microfluidic valve (Sershen et al., 
2002b, Sershen et al., 2005, Satarkar et al., 2009) and microlens (Kim et al., 2005) 
control. Additionally, the effects of these encapsulated nanoparticles on polymer bulk 
properties have been studied (Wang et al., 2004b, Wang et al., 2004a). 
2.3.1. Microfluidic Valves 
 Due to remote triggering of dramatic changes in material size and shape, 
thermally responsive polymer-nanoparticle conjugates have been investigated for use in 
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the controlled manipulation of valves in microfabricated devices. Sershen et al. proposed 
a combination of poly(NIPAAm-co-AAm) hydrogels, gold colloid particles, and gold-
silica nanoshells for use in independent control of multiple valves within a microfluidic 
device, as seen in Figure 2.9 (Sershen et al., 2002b, Sershen et al., 2005). Using these 
materials, independent control of two valves at a T-junction was achieved. One valve 
consisted of a poly(NIPAAm-co-AAm)-gold colloid composite while the other contained 
a poly(NIPAAm-co-AAm)- gold-silica nanoshell composite. When exposed to green 
(532 nm) light, the gold colloid channel opened and the gold-silica remained closed, but 
when exposed to NIR (832 nm) light, the gold-silica channel opened while the gold-
colloid channel remained closed (Sershen et al., 2005).  The authors noted that a larger 
number of independently controlled components could be achieved by using multiple 
nanoparticles with different absorption spectra, utilizing directed light, or tailoring the 
hydrogels to have differing LCSTs (Sershen et al., 2005).  
 39 
 
Figure 2.9. T junction in a microfluidic device formed by two valves; one made with 
a gold colloid nanocomposite hydrogel and one made of a gold nanoshell composite 
hydrogel. [A] After the entire device is illuminated with 532 nm light for 5 s, the gold 
colloid channel opens and the gold nanoshell remains closed [B] The opposite response is 
seen when the device is illuminated with 832 nm light. From (Sershen et al., 2005). 
2.3.2. Drug Delivery 
Photothermally modulated drug delivery was first shown by Sershen et al. using a 
combination of poly(NIPAAm-co-AAm) and gold-gold sulfide nanoparticles (Sershen et 
al., 2000). This study used hydrogels with a 95:5 molar ration of NIPAAm:AAm to 
achieve an LCST slightly above physiologic temperature. Upon NIR irradiation of these 
composites, the temperature of the hydrogel exceeds the LCST causing a burst release of 
any soluble molecules contained in the hydrogel matrix. Enhanced release of molecules 
such as methylene blue, ovalbumin, and bovine serum albumin was found to follow near 
infrared irradiation of the nanoparticle-composite hydrogels (Sershen et al., 2000).  
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Further investigation of this system showed that it could be applied to photothermal 
delivery of insulin (Sershen et al., 2002a). A similar system using the same hydrogel 
formation with gold-silica nanoshells also successfully demonstrated photothermal drug 
delivery (Bikram et al., 2007). Studies showed that the collapse of hydrogel-nanoshell 
composites was controlled by both laser fluence and gold-silica nanoshell concentration 
(Bikram et al., 2007). Photothermal release studies of methylene blue, insulin and 
lysozyme showed a pulsatile drug release that was dependent on the molecular weight of 
the molecule (Bikram et al., 2007). 
The optically-triggered cancer therapeutic delivery platform developed in this 
dissertation builds upon these successful studies utilizing poly(NIPAAm-co-AAm)-gold 
nanoshell composites. The methods used to synthesize and characterize these bulk 
poly(NIPAAm-co-AAm)-gold nanoshell composites are outlined in the remainder of this 
chapter, and initial validation of these materials to deliver cancer therapeutics is 
described in Chapter 3.    
2.4. Materials and Methods 
All reagents were purchased from Sigma-Aldrich and used as received, unless 
otherwise noted. All water used in synthesis, purification, and testing was treated by a 
Milli-Q system (≥18.0 MΩ.cm resistivity). 
2.4.1. Gold-Silica Nanoshell Synthesis 
Gold-silica nanoshells are synthesized using a four-step process that is outlined in 
this paragraph, with details to follow. First, silica nanoparticles are formed using the 
Stöber method, and then surface functionalized with amine groups using silane reagents. 
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Small gold colloid particles (~2 nm) are then adsorbed onto the aminated surface. These 
served as nucleation sites for a final reduction step in chloroauric acid, potassium 
carbonate, and formaldehyde, producing a gold shell around the silica particle. This 
synthesis process is summarized in Figure 2.10, accompanied by a TEM micrograph 
depicting shell growth (Oldenburg et al., 1998).  
For the first step of silica nanoparticle formation via the Stöber method (Stober et 
al., 1968), tetraethyl orthosilicate (TEOS) was reduced in ethanol (EtOH) in the presence 
of ammonium hydroxide (NH4OH). To achieve nanoparticle diameters of approximately 
120 nm, 0.5 g of NH4OH (28%) was added to 32.06 g 200 proof EtOH. With rapid 
stirring, 1.69 g of TEOS (99.999%) was added. The reaction mixture was rocked 
overnight at room temperature. The following day the particles were washed by three 
rounds of centrifugation (2500 x g, 30 min) and suspended in EtOH. The silica particles 
were then functionalized with amine groups via a reaction with 3-
aminopropyltriethoxysilane (APTES). For every 1 ml of cores at 4 wt%, 5 µl of APTES 
(Gelest, Inc.) was added under rapid stirring and allowed to react overnight at room 
temperature. The following day, the reaction solution was boiled for 2 hr to ensure 
surface exposure of amine groups. The suspension was then centrifuged three times 
(2500 x g, 30 min) and resuspended in EtOH.   
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Figure 2.10.  Gold-silica nanoshell synthesis. [A] The four steps of gold-silica 
nanoshell synthesis: (1) formation of silica core, (2) amine functionalization, (3) 
adsorption of gold colloid and (4) shell growth. [B] TEM image depicting shell growth 
on a silica core from adsorbed gold colloid (steps 3-4 from [A]). Adapted from 
(Oldenburg et al., 1998). 
Colloidal gold particles with a 2-4 nm diameter were prepared by a reduction of 
chloroauric acid (HAuCl4) as previously described in the literature (Duff et al., 1993). 
Briefly, a tetrakis(hydroxymethyl)phosphonium chloride (THPC, TCI America, 80%) 
solution was made by mixing 400 µl of THPC with 33 ml H2O.  Next, 4 ml of this THPC 
solution was added to 1.2 ml of 1 N sodium hydroxide (NaOH) and 180 ml of H2O. This 
solution was rapidly stirred for at least 5 min, and then 6.75 ml of 1 wt% HAuCl4 (Alfa 
Aesar, 99.999%) was added. The mixture was stirred until the suspension color stabilized 
(<1 min) and the product was stored at 4 oC. Generally this colloid suspension was aged 
for at least 2 weeks before being used in subsequent steps.  
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Aminated silica core particles were then mixed with this gold colloid suspension 
to create “seed” particles with the colloids being adsorbed onto the silica core via 
electrostatic interaction between the positively charged amine group and negatively 
charged colloids.  For this reaction, 30 ml of colloid suspension was mixed with 180 µl 
functionalized cores (at 4 wt%) and 1 ml of 1 M NaCl. The reaction mixture was rocked 
for at least 48 hr at room temperature and washed by two rounds of centrifugation (1500 
x g, 30 min) and resuspended in H2O. 
Nanoshell synthesis was completed by a shell growth step. A gold plating solution 
was made by combining 200 mg of potassium carbonate (K2CO3), 12 ml of 1% HauCl4, 
and 800 ml H2O. Various seed particle volumes (200-500 µl) were added to 1 ml of the 
plating solution. 10 µl of formaldehyde (HCHO, 37%) was added to each suspension 
with rapid mixing. This causes a reduction reaction in which the adsorbed colloids of the 
seed particles serve as nucleation sites for shell growth via deposition of reduced gold 
ions. Formulations that produced particles with an extinction profile peak near 800 nm 
were linearly scaled up. After synthesis, nanoshells were washed by one round of 
centrifugation (735 x g, 10 min) and resuspended in 1.81 mM K2CO3 for storage. Before 
use in subsequent applications, stored nanoshells were washed via one centrifugation 
round (735 x g, 10 min) and resuspended in H2O.  
After synthesis, particle extinction spectra from 400-1000 nm were collected 
using a Cary 50 Varian spectrophotometer. Nanoshells were also characterized by 
electron microscopy with an FEI Tecnai G2 Twin transition electron microscope (TEM). 
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Additionally, dynamic light scattering (DLS) was then used to measure the hydrodynamic 
diameter of the particles using a Malvern Zetasizer ZS. 
2.4.2. Poly(NIPAAm-co-Aam) Hydrogel Synthesis 
Poly(NIPAAm-co-Aam) hydrogels were synthesized using free radical-initiated 
addition polymerization. Prior to synthesis, NIPAAm (97%) was dissolved in 
tetrahydrofuran (THF) and recrystallized in n-hexane to remove the small molecule 
inhibitor p-methoxyphenol from the packaged NIPAAm. The recrystallization process 
was repeated at least 3 times and the final product was dried under vacuum and stored at  
-20 oC. Stock solutions of NIPAAm (1.75 M), AAm (≥99%, 15 M), and N,N’-
methylenebisacrylamide (MBAAm) (≥98%,  0.169 M) were prepared in water. A 
prepolymer solution of a 95:5 molar ratio of NIPAAm:AAm and a 1:750 molar ratio of 
monomer:crosslinker (MBAAm) was prepared from the stock solutions: 3.56 ml 1.75 M 
NIPAAm, 21.88 µl 15 M AAm, and 51.78 µl 0.169 M MBAAm and 116.34 µl H2O were 
added to a three-neck round bottom flask (3.75 ml total). Argon (Ar) gas was bubbled 
through this solution for at least 15 min in order to remove dissolved O2, which inhibits 
the polymerization process. With rapid stirring, 37.5 µl of 10% (w/v) ammonium 
persulfate (APS, ≥98%) in H2O and 7.5 µl of N,N,N′,N′-tetramethylethylenediamine 
(TEMED,  ≥99%) were added to initiate the redox reaction for free radical 
polymerization. To synthesize composite hydrogels, nanoshells were added to a 
concentration of 8 x 109 nanoshells/ml to the monomer solution prior to adding 
APS/TEMED. The polymerization solution was then quickly poured into a mold 
consisting of 2 glass slides separated by a 1.5 mm Teflon® spacer held together by metal 
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clamps. The hydrogel was then cured at 30 oC for 2 h. After curing, the hydrogel slab was 
soaked in 95% EtOH for at least 12 hr followed by H2O for at least 12 hr to remove any 
initiators and unreacted monomers. Hydrogel disks (4 mm diameter) were punched out of 
the hydrogel slab with a cork borer. A schematic of this polymerization process is shown 
in Figure 2.11. 
 
Figure 2.11. Poly(NIPAAm-co-AAm) hydrogel synthesis. A solution of a 95:5 molar 
ratio of the monomers NIPAAm:AAm and a 1:750 ratio of crosslinker 
MBAAm:monmers is polymerized by free radical polymerization initiated by APS and 
TEMED. 
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2.4.3. Poly(NIPAAm-co-AAm) Hydrogel Morphology and Mesh Size 
Differences in the mesh size of poly(NIPAAm-co-AAm) hydrogels and 
poly(NIPAAm-co-AAm)-nanoshell composite hydrogels were assessed using a method 
similar to that used by Weber et al. (Weber, Lopez, and Anseth 2009). Hydrogels of a 4 
mm diameter and 2 mm height were dried under vacuum overnight and then soaked in a 1 
mg/ml solution of trypsin inhibitor (MW = 20,000 Da) in phosphate-buffered saline 
(PBS, pH 7.4) for 48 hr at 4 oC. Hydrogels were then placed in fresh PBS and release of 
the trypsin inhibitor was analyzed over 120 min by taking aliquots of the soak solution 
and analyzing for protein content using a Micro BSA Protein Assay (Thermo Scientific). 
To determine the diffusion coefficient of the protein through the hydrogel, the release 
profiles were fit to Equation 2.6 (Crank 1975):  
𝑀𝑡
𝑀! = 1− 6𝜋! 1𝑛!!𝑛!! exp  (−𝐷𝑛!𝜋!𝑡𝑎! ) Equation 2.6    
where Mt is the amount of protein that has diffused out of the hydrogel at time t; M∞ is 
the amount of protein that has diffused out after time equals infinity (here estimated after 
72 hr), D is the diffusion coefficient of the protein through the hydrogel, and a is the 
radius of the hydrogel (4 mm).  
The mesh size of the hydrogel networks (ξ) is related to the diffusion coefficient 
of a given solute by Equation 2.7: 
𝐷𝑔
𝐷𝑜
= 1− 𝑟𝑠𝜉 exp  (−Υ 𝑣!1− 𝑣! ) Equation 2.7   
 47 
where Dg is the diffusion coefficient of the solute through the hydrogel calculated from 
Equation 2.3, Do is the diffusion coefficient of the solute in solution (1.45 cm2/s  x 106) 
(Weber et al., 2009), rs is the solute (trypsin inhibitor) radius (2.19 nm) (Weber et al., 
2009), Υ is the ratio of the volume required for translational movement of the solute to 
the average free volume per liquid molecule, and is generally approximated to be 1, and 
v2 is the volumetric swelling ratio (Weber et al., 2009). The volumetric swelling ratio was 
calculated using Equation 2.8: 
𝑣! = 1+ 𝜌𝑐𝜌𝑠 (𝑀𝑠𝑀𝑑 − 1) Equation 2.8    
where ρc and ρs are the densities of the composite material and solvent, respectively; and 
Ms and Md are the swollen and dry masses of the hydrogel, respectively.  
2.4.4. Poly(NIPAAm-co-AAm) Hydrogel Deswelling  
The swelling behavior of the poly(NIPAAm-co-AAm) gels was analyzed in 
response to changes in temperature. The hydrogels were allowed to swell at room 
temperature (22 oC) for at least 24 hr before testing. To determine the LCST of the 
hydrogels, the gels were first weighed and placed in TRIS-buffered saline (TBS, pH 7.4) 
and then incubated at various temperatures (29 oC, 33 oC, 37 oC, 41 oC, 45 oC, and 50 oC) 
for 10 min. After incubation, the gels were weighed again and the deswelling of the gel 
was calculated using Equation 2.9. 
 𝐷𝑒𝑠𝑤𝑒𝑙𝑙𝑖𝑛𝑔  𝑅𝑎𝑡𝑖𝑜   % = 100 ∗𝑊𝑒𝑖𝑔ℎ𝑡𝑇𝑒𝑚𝑝 𝑊𝑒𝑖𝑔ℎ𝑡𝑇𝑒𝑚𝑝!  !!𝑜𝐶       Equation 2.9   
Additionally, the thermal behaviors of hydrogels with and without nanoshells 
were compared. These gels were either incubated at 50 oC or exposed to an NIR laser and 
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weighed at various times. For this test, gels were placed in 2 ml TBS and incubated in a 
50 oC water bath. Gels were weighed every 10 min for 30 min and the deswelling of the 
gel was calculated using Equation 2.10. 𝐷𝑒𝑠𝑤𝑒𝑙𝑙𝑖𝑛𝑔  𝑅𝑎𝑡𝑖𝑜   % =   100 ∗𝑊𝑒𝑖𝑔ℎ𝑡! 𝑊𝑒𝑖𝑔ℎ𝑡!!!   Equation 2.10     
The thermal behavior of gels with and without nanoshells in response to NIR 
irradiation was then analyzed. Gels were placed in 2 ml of TBS and exposed to an NIR 
laser (Coherent Diode, 808 nm, 8 W/cm2, 30 min). The gels were weighed every 10 min 
for 30 min and the deswelling of the gel was calculated using Equation 2.10.  
2.5. Results 
2.5.1. Gold-Silica Nanoshell Characterization 
As synthesized, the nanoshells utilized in this study were found to have a diameter 
of 153 ± 9 nm (as analyzed by TEM) and a Z-average diameter of 156.0 nm and a 
polydispersity index of 0.090 (as analyzed by DLS). These particles strongly absorb in 
the near infrared (NIR), with a peak extinction coefficient at 780 nm. A TEM image of 
the gold-silica nanoshells and their extinction spectra are shown in Figure 2.12. 
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Figure 2.12. Gold-silica nanoshell characterization. [A] TEM image of synthesized 
gold-silica nanoshells. Scale bars = 500 nm, 100 nm (inset).  [B] Extinction spectra of 
synthesized gold-silica nanoshells. Particles were synthesized to have maximum light 
absorption in the NIR region.  
2.5.2. Poly(NIPAAm-co-AAm) Hydrogel Morphology and Mesh Size 
Release profiles of trypsin inhibitor from composites with and without nanoshells 
are shown in Figure 2.13. From these release profile fits, diffusion coefficients of trypsin 
inhibitor and mesh sizes for hydrogels with and without nanoshells were calculated using 
Equations 2.4 and 2.5. Both were found to be similar, indicating diffusive transport 
through both materials is comparable, and are displayed in Table 2.2 . 
Table 2.2. Calculated diffusion coefficients and mesh sizes for hydrogels with and 
without nanoshells.  
 Diffusion Coefficient (D) 
(cm2/s x 106) 
Mesh Size (ξ) 
(nm) 
Nanoshells 0.70 ± 0.11 2.60 ± 0.07 
No Nanoshells 0.89 ± 0.08 2.78 ± 0.07 
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Figure 2.13. Release of trypsin inhibitor from hydrogels with (blue) and without 
(red) nanoshells. Experimentally measured release data are shown as individual data 
points, and the theoretical release profiles (based on release data fitted to Equation 2.4) 
are shown as solid lines.  
2.5.3. Poly(NIPAAm-co-AAm) Hydrogel Deswelling 
Hydrogel deswelling results, illustrated in Figure 2.14, show that these gels 
collapsed from 39-45 oC, a temperature range slightly above physiologic temperature.  
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Figure 2.14. LCST Determination. Deswelling of NIPAAm-co-AAm hydrogels as a 
function of temperature. These hydrogels collapse from 39-45oC. Deswelling ratio was 
calculated using Equation 2.9. 
Additionally, deswelling behavior of this material can be tuned by adjusting the monomer 
and crosslinker concentrations used, with the incorporation of more hydrophillic 
molecules (AAm and MBAAm vs. NIPAAm) raising the temperature at which the 
transition occurs and decreasing the overall amount of deswelling. This is illustrated in 
Figure 2.15, which compares the deswelling behavior of hydrogels containing a 95:5 and 
90:10 molar ratio of NIPAAm:AAm (both with 1:750 molar ratio of 
crosslinker:monomers).  
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Figure 2.15. Thermal deswelling of poly(NIPAAm-co-AAm) hydrogels with 95:5 and 
90:10 NIPAAm:AAm. 
Next, hydrogel deswelling in response to NIR exposure was analyzed. Results are 
shown in Figure 2.16. Both gels with and without nanoshells display similar behavior 
when incubated at 50 oC, indicating that the presence of nanoshells does not inhibit 
hydrogel collapse. When exposed to the NIR laser, gels with nanoshells deswell similarly 
to the gels incubated at 50 oC, while gels without nanoshells exhibit minimal deswelling 
in response to the laser. This proves that both the presence of nanoshells and exposure to 
an NIR laser are required to drive gel deswelling.   
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Figure 2.16. Deswelling in response to temperature changes and irradiation. 
Deswelling of NIPAAm-co-AAm hydrogels with (solid lines) and without (dashed lines) 
nanoshells by either incubation in a 50 oC water bath (squares) or exposure to a NIR laser 
(808 nm, 8 W/cm2) (ciricles). Both materials displayed similar deswelling behaviors 
when incubated above material LCST, while only hydrogels with the nanoshells showed 
deswelling in response to NIR irradiation. Deswelling ratio was calculated using 
Equation 2.10. 
2.6. Conclusions 
In this chapter, a poly(NIPAAm-co-AAm)-gold nanoshell composite material was 
synthesized. This material had an LCST of around 39-45 oC, meaning it was swollen at 
physiologic temperature. Expulsion of absorbed water and collapse of the material was 
found to follow both incubation at 50 oC and exposure to a NIR laser. With these results, 
we moved forward to use this optically induced phase transition to trigger drug release 
from the material, as described in Chapter 3. 
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3. Drug Loading and Release from Poly(NIPAAm-co-
AAm)-Gold Nanoshell Composites2 
In this chapter, the ability to load and trigger release of therapeutic molecules 
from the bulk nanoshell-hydrogel composites described in Chapter 2 is investigated. The 
composite material was loaded with two different cancer therapeutics, and release of both 
these therapeutics from the material in response to NIR exposure was assessed. A 
schematic of this process is illustrated in Figure 3.1. Subsequently, the cellular uptake 
and biological efficacy of a delivered chemotherapeutic was analyzed in vitro in a murine 
colon carcinoma cell line.  
 
Figure 3.1. Schematic of drug delivery from bulk hydrogel-nanoshell composites. 
                                                
 
2 Portions of this chapter are adapted from: Strong L.E., Dahotre S.N, and West, J.L. Hydrogel-nanoparticle 
composites for optically modulated cancer therapeutic delivery. J. Control. Release. 178(8): 63-68 (2014).  
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3.1. Drug Payload 
Release of two therapeutics: a chemotherapeutic (doxorubicin) and a biologic 
therapeutic (siRNA targeting EphA2) were assessed. These are both used in the treatment 
of various cancers and also represent opposite ends of the delivery spectrum in terms of 
molecular size and hydrophobicity. Doxorubicin is a hydrophobic small molecule (580 
Da) chemotherapeutic indicated in a wide variety of cancers including hematopoietic 
malignancies; carcinomas of the breast, lung, ovary, stomach, and thyroid; and sarcomas 
of bone and soft tissue (Rubin and Williams, 2001). The primary mechanism of action is 
intercalation with DNA during replication, causing inhibition of topoisomerase II binding 
and arrest of cell replication (Fornari et al., 1994). Side effects of doxorubicin include 
myelosuppression, mucositis, and cardiac toxicity; furthermore, these side effects often 
cause patients to cease doxorubicin therapy, even if the drug is effective against their 
malignancy (Saltiel and McGuire, 1983).  
The second therapeutic analyzed was a short DNA duplex used as a model 
molecule for siRNA. Typical siRNAs are double-stranded with sticky ends and molecular 
weights of 12-15 kDa. This study employed a 21 base pair (12,850.5 kDa) 
oligonucleotide equivalent in sequence to an siRNA targeting the EphA2 protein (target 
sequence 5’-AATGACATGCCGATCTACATG-3’) (Duxbury et al., 2004). EphA2 is a 
receptor tyrosine kinase known to be upregulated in many cancers; its functions include 
signaling involved in cell-cell contacts, cell migration, and angiogenesis (Gale and 
Yancopoulos, 1999). Down regulation of EphA2 has been shown to reduce 
tumorigenicity in preclinical studies of several cancer types, including pancreatic and 
 56 
breast carcinomas (Landen et al., 2005).   A comparison of these two therapeutics is 
shown in Table 3.1.  
Table 3.1. Comparison of Doxorubicin and siRNA. 
 Doxorubicin siRNA 
Drug type Chemical Biologic 
Size 580 Da 13-15 kDa 
Chemical Properties Hydrophobic Hydrophillic 
Intracellular Transport Passive diffusion Endosomal 
Mechanism of Action Inhibition of topoisomerase 
II 
Prevents translation of 
complimentary mRNA 
sequences 
Benefits for controlled 
delivery 
Minimize off-site toxicity Increase serum stability 
Detection methods Absorbance (485 nm) or 
fluorescence (585 nm) 
Absorbance at 260 nm 
 
3.2. Materials and Methods 
All reagents were purchased from Sigma-Aldrich and used as received, unless 
otherwise noted. All water used in synthesis, purification, and testing was treated by a 
Milli-Q system (≥18.0 MΩ.cm resistivity). 
3.2.1. Therapeutic Loading 
Hydrogels with and without nanoshells were dried under vacuum for at least 48 hr 
prior to drug loading. The dry weights of the hydrogels were recorded. One set of 
hydrogels was then soaked in a 0.5 mg/ml (862 µM) solution of doxorubicin in TBS at 4o 
C for 24 hr. Absorbance readings of loaded hydrogels at 485 nm were used to determine 
the loaded concentration of doxorubicin, with absorbance readings of non-drug loaded 
hydrogels used as blanks. A separate set of hydrogels was soaked in a 0.22 mg/ml (17 
µM) solution of a 21-bp DNA duplex (Integrated DNA Technologies, inc.) in duplex 
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buffer (30 mM HEPES, 100 mM potassium acetate, pH 7.5; Integrated DNA 
Technologies, inc.) at 4 oC for 24 hr. DNA duplex loading was estimated by measuring 
the concentration of DNA in the soak solution before and after hydrogel soaking. 
3.2.2. Therapeutic Release 
Loaded hydrogels, both with and without nanoshells, were placed in TBS 
(doxorubicin hydrogels) or duplex buffer (DNA duplex hydrogels) and then exposed to 
an NIR diode laser (Coherent) at 808 nm, 8 W/cm2 for 30 min. In addition, control 
hydrogels with nanoshells were kept at room temperature (~22 oC) for 30 min to evaluate 
release due to passive diffusion. Every 5 min, a buffer sample was analyzed for drug 
content via absorbance measurements (doxorubicin, 485 nm; DNA, 260 nm). Release 
profiles from these three groups were analyzed using an ANOVA with Tukey’s HSD. 
3.2.3. Analysis of Delivered dsDNA 
To ensure that the heating of the gel during the material transition did not 
denature the dsDNA oligo, the delivered product was run on a native poly(acrylamide) 
gel. A 20% poly(acrylamide) gel was synthesized by mixing a 19:1 molar ratio of 
AAm:MBAAm in tris-acetate-EDTA (TAE) buffer. The gel had a volume of ~20 ml and 
was polymerized by the addition of 300 µl 10% APS (w/v in H2O) and 30 µl TEMED.  
The gel was loaded with a 10 bp ladder, the annealed dsDNA oligo as a positive control, 
and dsDNA oligo obtained from irradiating a loaded composite gel at for 30 min (808 
nm, 8 W/cm2). The gel was run at 120 V for 3 hr and subsequently stained for 
visualization using both SYBR Gold and SYBR Green (Life Technologies). For staining, 
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gels were incubated in 150 ml of a 1X solution of each stain in TAE buffer for 15 
minutes at room temperature.  
3.2.4. In vitro Validation 
Murine colon carcinoma cells (CT-26.WT cells, ATCC) were cultured in RPMI 
1640 media (ATCC) supplemented with 2 mM L-glutamine, 10 mM HEPES, 1 mM 
sodium pyruvate, 4.5 g/L glucose, 1.5 g/L sodium bicarbonate, 1% penicillin, 1% 
streptomycin, and 10% fetal bovine serum (FBS). Cultures were maintained at 37 oC with 
5% CO2. 
Cells were seeded in fibronectin-coated 24-well culture plates at a density of 
75,000 cells/well. After 24 hr, either a doxorubicin-loaded composite hydrogel or a non-
loaded composite hydrogel was placed in a transwell insert (PET membrane, 0.4 µm pore 
size, Becton, Dickinson and Co.) and covered with media. The hydrogels were then 
exposed to the NIR laser (808 nm, 8 W/cm2, 10 min) after which the hydrogel and insert 
were removed, leaving behind only the delivered drug in the culture media, and the cells 
were incubated for an additional 24-48 hr. Additional groups included cells that were 
exposed to loaded composite hydrogels for both 10 min (equivalent time as NIR 
exposure) and 24 hr as controls, as well as cells which were exposed to 5.4 µg of free 
dox/well (approximately the amount of doxorubicin that was released from one gel 
following 10 min of irradiation, results in a drug concentration of ~9.3 µM). After 24 hr, 
cellular uptake of doxorubicin was assayed by fluorescent microscopy (560 nm 
excitation, 645 nm emission) using an Axiovert 135 inverted fluorescent microscope 
(Zeiss). Doxorubicin fluorescent intensity was quantified using ImageJ (NIH) and 
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analyzed using a Student’s t-test. After 48 h, cell proliferation was assessed using a 
CellTiter96® AQueous proliferation assay (Promega). Using this absorbance-based 
assay, cell proliferation was normalized to the proliferation of non-treated cells, and 
proliferation changes among the groups were analyzed using an ANOVA with Tukey’s 
HSD.  
3.3. Results 
3.3.1. Therapeutic Loading 
In separate studies, a chemotherapeutic (doxorubicin) and a biologic therapy 
(dsDNA, as a model for siRNA) were passively absorbed into the material, with amounts 
of drug loaded shown in Table 3.2. 
Table 3.2. Drug Loading of Hydrogel Composites. 
With Nanoshells Without Nanoshells 
 Doxorubicin dsDNA Doxorubicin dsDNA 
 466.5 ± 2.6 221.0 ± 13.1 418.3 ± 5.1 209.7 ± 0.9 µg drug loaded / g gel 
17.4 ± 1.7 9.0 ± 0.5 15.6 ± 2.0 6.6 ± 0.6 µg of drug per hydrogel disk 
 
3.3.2. Therapeutic Release 
Doxorubicin delivery after NIR irradiation indicated that the material with 
encapsulated nanoshells displayed increased release over controls for all times t > 0 
(Figure 3.2). After 30 min, delivery of doxorubicin from the irradiated composite 
hydrogels was approximately 2 times higher than irradiation of hydrogels without 
nanoshells. (329 µg/g compared to 158 µg/g).  
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Figure 3.2. Release of doxorubicin from poly(NIPAAm-co-AAm)-nanoshell 
composite hydrogels. Gels containing nanoshells exposed to an 808 nm laser at 8 W/cm2 
(blue) delivered significantly more drug than gels without nanoshells exposed to the same 
laser settings (red) and gels with nanoshells left at room temperature as a control (green). 
*p<0.05, **p<0.01. 
Delivery of dsDNA delivery from irradiated composites was nearly 5 times higher 
than irradiated hydrogels without nanoshells (197.8 µg/g vs 39.68 µg/g) after 30 minutes 
(Figure 3.3). Overall, 71% of loaded doxorubicin was released from the composite 
hydrogels after 30 minutes of irradiation, compared to 93% loaded dsDNA. At time 
points longer than 30 min it is predicted that more doxorubicin will slowly release from 
the composite due to passive diffusion, however at this point the phase transition of the 
hydrogel is complete so there will no longer be a convective flow of drug from the 
material. Additionally, differences in passive diffusion out of the composite were seen for 
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the two drugs. A larger amount of doxorubicin diffused out of the composite compared to 
the dsDNA (158 µg/g over 30 minutes vs. 39.68 µg/g). This is likely due to the overall 
size of the two drugs, with the larger size of the dsDNA therapeutic slowing its diffusion.  
 
Figure 3.3. Release of DNA duplexes from poly(NIPAAm-co-AAm)-nanoshell 
composite hydrogels. Gels containing nanoshells exposed to an 808 nm laser at 8 W/cm2 
(blue) delivered significantly more drug than gels without nanoshells exposed to the same 
laser settings (red) and gels with nanoshells left at room temperature as a control (green). 
**p<0.01. 
In a separate study using doxorubicin-loaded composite hydrogels, NIR light 
exposure was cycled on and off over a 30 min period (10 min off, 10 min on, 10 min off) 
to further demonstrate the dependence of release kinetics on NIR exposure, as seen in 
Figure 3.4.   
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Figure 3.4. NIR exposure effects release kinetics. Delivery of doxorubicin from 
composite hydrogels exposed to cyclic NIR irradiation (10 min off, 10 min on, 10 min 
off) shows that the rate of release from the composite greatly increases in response to 
NIR exposure. 
3.3.3. Analysis of Delivered dsDNA 
The integrity of the delivered dsDNA was assessed using gel electrophoresis. 
After gel electrophoresis, the delivered DNA was stained with both SYBR gold and 
SYBR green. SYBR gold stains all DNA content, while SYBR green preferentially stains 
dsDNA. The gel was then imaged under UV fluorescence, with the results shown in 
Figure 3.5.   
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Figure 3.5. PAGE of delivered DNA. Gel electrophoresis of [1] 10 bp ladder, [2] 
annealed dsDNA olignucleotide, and [3] dsDNA olignucleotide delivered from hydrogel-
nanoshell composite via NIR irradiation. Delivered dsDNA ran as a single band at 21 bp, 
the same size as the annealed dsDNA control. 
Results from Figure 3.5 showed that the delivered dsDNA ran as a single band at 
21 bp, the same size as the annealed dsDNA control. Under SYBR Gold staining, there 
were no bands present below the band at 21 bp, which would have indicated the presence 
of lower MW ssDNA. This suggests the delivered dsDNA oligo was in its double-
stranded form.  
3.3.4. In vitro Validation 
To evaluate cellular uptake and biological efficacy, doxorubicin was released from 
these hydrogel composites and allowed to act on cultured colon carcinoma cells. After 24 
hr, cells exposed to irradiated hydrogels showed increased intracellular doxorubicin as 
compared to cells exposed to non-irradiated hydrogels (Figure 3.6[A-C]). Cells that were 
exposed to the irradiated hydrogels containing doxorubicin showed a 30% decrease in 
proliferation (Figure 3.6[D]) in response to doxorubicin exposure, whereas cells cultured 
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with a non-irradiated doxorubicin composite exhibited minimal changes in proliferation, 
indicating that the loaded doxorubicin was available to cells only when hydrogels were 
forced to undergo their thermal phase transition. Further, cells exposed to free 
doxorubicin showed a similar decrease in proliferation as was seen in the irradiated 
composite group. Cells exposed to irradiated gels that were not loaded with drug did not 
exhibit any decrease in proliferation. 
 
Figure 3.6. Doxorubicin delivery to CT26-WT cells.  [A] Phase images overlayed with 
doxorubicin fluorescent signal of cells exposed to irradiated composite hydrogels [A] and 
non-irradiated composite hydrogels [B]. Scale bars = 50 µm. [C] Quantification of 
intracellular doxorubicin fluorescence. Cells exposed to irradiated gels have a 
significantly higher doxorubicin signal than cells exposed to non-irradiated gels (p<0.05). 
[D] Changes in cell proliferation due to doxorubicin delivery from composite gels. Cells 
exposed to irradiated gels showed a significant decrease in proliferation (p<0.05) 
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compared to cells exposed to non-irradiated gels, even approaching the response of cells 
exposed to free doxorubicin. 
3.4. Discussion 
The goal of the studies described in Chapters 2 and 3 of this dissertation was to 
design and investigate materials for an optically-triggered cancer therapeutic delivery 
platform. Materials used in such a platform need to act to (1) encapsulate a therapeutic 
cargo to limit tissue exposure before desired delivery, and (2) trigger release of this cargo 
at a specific time and location. The first goal was accomplished by the utilization of a 
thermally-responsive poly(NIPAAm-co-AAm) hydrogel. This material acts similarly to a 
sponge, allowing therapeutic molecules to be absorbed within its pores. In addition, this 
hydrogel was found to have an LCST slightly above 37 oC, thereby existing in a swollen 
state at human body temperature, but going through the desired phase change at 
temperatures easily achievable with minimal biological consequences. 
The second goal, triggering the phase transition, was accomplished by the 
encapsulation of gold-silica nanoshells within the hydrogel. When exposed to light in the 
NIR range, the nanoshells elicited a temperature increase of the surrounding material. 
This caused the hydrogel material to collapse and rapidly expel large amounts of water 
and absorbed therapeutic, demonstrating the capability of optically triggering this 
material phase transition and subsequent drug delivery.  
The loading and release of this therapeutics from the system showed some 
differing characteristics. For loading of both doxorubicin and dsDNA, a higher amount of 
drug could be loaded into the composite hydrogels with nanoshells compared to the 
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polymer-only hydrogels. Overall, a higher concentration of doxorubicin (836 µM) was 
loaded into the hydrogels than the DNA duplexes (17 µM). This is because doxorubicin 
is a much smaller molecule, and can therefore easily diffuse into the hydrogel material 
during loading. However, this same property causes doxorubicin to passively diffuse out 
of the material much faster than the DNA, leading to higher levels of non-triggered 
delivery (158 µg/g gel doxorubicin release seen at room temperature vs 40 µg/g dsDNA 
release). In addition, despite its small size, an overall lower percentage of doxorubicin 
delivery is seen over 30 min when compared to dsDNA (71% doxorubicin delivered 
following irradiation, as compared to 93% dsDNA delivered). This is likely due to the 
chemical nature of the therapeutic being delivered. Hydrophillic molecules are more 
advantageous for this system, as the material phase transition is based upon the 
hydrophobic effect, with the hydrophobic polymer material phase separating from its 
aqueous environment. Therapeutics molecules that are more hydrophobic will have 
increased affinity to the polymer material, causing them to remain encapsulated within 
the hydrogel material following water expulsion, as illustrated in Figure 3.7. 
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Figure 3.7. Delivery of hydrophillic vs. hydrophobic drugs. More hydrophobic drugs 
have a higher affinity for the polymer phase during transition than hydrophillic drugs. 
This causes some amount of hydrophobic drug to remain in the polymer phase following 
the transition, leading to a lower percent of encapsulated drug delivered.  
3.5. Conclusions  
These studies validate the potential for this composite material to be used for 
controlled delivery of cancer therapeutics. Towards translation of this material into in 
vivo applications, the composites could be synthesized as injectable-sized particles rather 
than bulk discs. This would allow for a platform of similar size as liposomal drug 
formulations, thus allowing for passive targeting of intravenously administered particles 
to tumor tissue due to the enhanced permeation and retention effect (Matsumura and 
Maeda, 1986), as illustrated in Figure 3.8. 
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Figure 3.8.  Nanoparticle accumulation due to the EPR effect. Intravenously injected 
nanoparticles passively accumulate in tumor tissue due to leaky tumor vasculature and 
poor lymphatic drainage. Adapted from (Dong and Mumper, 2010).   
After accumulation of particles in tumor tissue, release of drug from the carrier 
would then be triggered by external NIR exposure. The next two chapters of this 
dissertation will discuss the synthesis of such a platform.  
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4. Hydrogel-Nanoshell Composite Particles: Synthesis 
Using the Hydrogel Template Method 
In the previous two chapters of this dissertation, a composite material for 
optically-triggered drug delivery was synthesized and validated, demonstrating that NIR 
absorption by nanoshells can drive phase changes in poly(NIPAAm-co-AAm) hydrogels, 
and thus trigger increased drug delivery. The next goal was to synthesize this material as 
individual particles smaller than 1 micron. These composite particles will be of a similar 
size to the nanoshells used in the studies discussed in Section 2.1.3.2, with only a thin 
layer of hydrogel added to the nanoshell surface; therefore the particles should be able to 
be injected intravenously and should passively accumulate in most types of tumor tissue 
due to the EPR effect. Once the particles reach the tumor site, an NIR laser will be 
applied to the tumor. As previously described, optical absorption by the nanoshells will 
cause a rapid heating of the embedded nanoshells, which in turn should trigger a collapse 
of the polymer coating and release of absorbed drug molecule directly at the tumor site. 
Figure 4.1 below illustrates this process. 
 
Figure 4.1. Schematic of hydrogel-nanoshell composite particle therapy. (1) Injected 
particles will circulate and passively accumulate into tumor tissue. (2) An applied NIR 
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laser causes rapid heating of the embedded nanoshells. (3) The resulting temperature 
increase causes release of absorbed drug molecules from the thermally responsive coating 
directly at the tumor site.  
This platform has the inherit ability to cause destruction of the tumor by two 
mechanisms simultaneously. The encapsulated nanoshells can be used to generate 
sufficient heating to cause hyperthermic therapy, as well as allow for a burst release of a 
pharmaceutical payload. Further, numerous studies have shown enhanced efficacy of 
chemotherapeutic treatments when combined hyperthermic treatments (Hildebrandt et al., 
2002, Hahn, 1979, Marmor, 1979).  In fact, combining hyperthermia and drugs has been 
shown to elicit a more than additive response for multiple classes of chemotherapeutic 
agents, including platinum drugs, alkylating agents, nitrosources, and antibiotics (Issels, 
2008).  
In addition to platforms consisting of thermally-responsive hydrogel-nanoparticle 
composites, composites consisting of temperature-sensitive liposomes or elastin-like 
polypeptides and gold nanoparticles have been studied.  The following section briefly 
outlines these platforms. 
4.1. Platforms Utilizing Liposomes and ELP Coatings 
4.1.1. Temperature-Sensitive Liposomes  
In addition to thermally-responsive hydrogels, temperature-sensitive liposomes 
(TSLs) have been investigated for drug delivery applications, with some formulations 
reaching clinical trials (Dromi et al., 2007). Many TSLs utilize dipalmitoyl 
phosphatidylcholine (DPPC) lipids, which display an acyl-chain melting phase transition 
at 41 oC (Ponce et al., 2006). When transitioning from below to above 41 oC, DPPC 
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transitions from a solid (crystalline) phase to a liquid phase, resulting in leakage of the 
liposome’s contents (Ponce et al., 2006). Additionally, this release can be enhanced by 
incorporating micelle-forming lysolipids, such as monostearoyl phosphatidylcholine 
(MSPC), into the lipid bilayer (Needham et al., 2000).   
Recent work by Qin et al. aimed to combine a TSL with gold nanoparticles 
attached to the surface (Qin et al., 2011).  The characteristics of this system are described 
in Figure 4.2. This system was tested with doxorubicin and was found to retain the 
encapsulated drug at 40 oC for 3 days and instantaneously release over 70% of the 
encapsulated drug upon exposure to a 532 nm laser. Further research is being done to 
tether hollow gold nanoshells, which have a surface plasmon peak in the near infrared 
range, instead of solid gold nanoparticles, to allow the system to be used in clinical 
applications (Qin et al., 2011). Other groups have looked at remote control release from 
thermo-sensitive liposomes by separate injections of liposomes and gold nanorods 
(Agarwal et al., 2011).  
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Figure 4.2. Properties of thermally responsive lipsome-gold nanoparticle complexes. 
[A] Schematic of drug release process. [B] UV-vis absorption spectrum of the gold 
nanoparticles used. [C] Cryo-TEM image of a liposome tethered to a gold nanoparticle 
[D] Cryo-TEM image of a liposome-nanoparticle complex after irradiation with a 532 nm 
laser. From (Qin et al., 2011). 
4.1.2. Elastin-Like Polypeptide Coatings 
Additionally, composite particles consisting of gold nanoparticles and ELPs have 
been investigated. Huang et al. developed an optically responsive ELP-gold nanorod 
system (Huang et al., 2008). A novel 22 kDa cysteine containing ELP was conjugated to 
NIR absorbing gold nanorods by gold-thiol bonds (Huang et al., 2008). The transition 
temperature (Tt) of the ELP was determined to be 33.4 oC; above this temperature the 
particles aggregated together resulting in an increase in optical density.  NIR irradiation 
of these particles resulted in an optical response due to a conformational change in the 
ELP (Huang et al., 2008).  
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4.2. Synthesis of Nanoscale Hydrogel Particles 
While the studies described above utilized liposomes or ELPs as the thermally-
sensitive component, several methods have been developed to synthesize nanoscale 
particles consisting of synthetic polymers. Many of these methods are based on soft 
lithography techniques (Jeong et al., 2010). Soft lithography is generally characterized by 
the creation of an elastomeric stamp or mold using microfabrication techniques 
developed in the electronics industry (Jeong et al., 2010). Two such techniques include 
Particle Replication In Nonwetting Templates (PRINT) (Rolland et al., 2005) and the 
hydrogel template method (Acharya et al., 2010a). In this chapter, the hydrogel template 
method will be adapted to synthesize poly(NIPAAm-co-AAm)-gold nanoshell composite 
particles.  
4.2.1. PRINT 
The PRINT method developed by the DeSimone group uses photocurable 
perfluoropolyether (PFPE) molds to emboss a prepolymer solution onto a highly 
fluorinated surface (Rolland et al., 2005). Such surfaces are nonwetting to organic 
materials, thereby allowing for synthesis of individual particles, as seen in Figure 4.3 
(Rolland et al., 2005).  
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Figure 4.3. PRINT compared to traditional imprint lithography. In traditional 
imprint lithography, the affinity of the liquid precursor to the surface of the substrate 
results in a scum layer. In PRINT, the non-wetting surface causes the liquid precursor to 
be confined only in the wells of the mold, resulting in the synthesis of isolated particles. 
From (Rolland et al., 2005). 
This method has been used to synthesize various different particles made of 
materials such as poly(D-lactic acid), PEG hydrogels, and proteins, with sizes ranging 
from 80 nm to 20 µm (Rolland et al., 2005, Kelly and DeSimone, 2008). Particles have 
been synthesized to be pH sensitive (Petros et al., 2008, Parrott et al., 2010), and have 
been loaded with chemotherapeutics (Petros et al., 2008) and contrast agents (Parrott et 
al., 2012, Nunes et al., 2010).  
chemical structure that would be necessary to fabricate and
harvest organic particles.
Here, we report a very general technique, Particle Replication
In Nonwetting Templates (PRINT), for the fabrication of
monodisperse particles with simultaneous control over structure
(i.e., shape, size, composition) and function (i.e., cargo, surface
structure). To demonstrate the utility and generality of PRINT
for particle generation, we have fabricated monodisperse,
multifunctional particles from technologically relevant materials,
including poly(ethylene glycol), poly(D-lactic acid), poly-
(pyrrole), and a triacrylate resin, with sizes below 200 nm and
with precise shape control. The compatibility of PRINT with
fragile biological cargos and recognition agents is demonstrated
by incorporating DNA, proteins, and small-molecule therapeu-
tics into sub-200 nm poly(ethylene glycol) nanoparticles using
a simple and general encapsulation technique. The ability to
independently control particle characteristics, such as size, shap ,
composition, cargo, and surface structure, makes PRINT
uniquely suited to fabricate particles for many applications.
PRINT addresses many of t e fundamental shortcomings of
other particle fabrication methods. It enables the top-down
fabrication to below 100 nm dimensions with orthogonal control
of size, shape, and composition by taking advantage of
significant advances in “soft lithographic” molding technology
that were developed to achieve this goal. This scalable method
to generate and harvest nanoparticles enables the possibility of
a “particle foundry”sthe functional equivalent of the continuous
fabrication methodologies employed by the microelectronics
industrysfor fabricating delicate organic particles necessary for
use in nanomedicine and other emerging nanotechnologies.
Here, we have used photocurable perfluoropolyether (PFPE)
molds to emboss liquid precursor compounds using highly
fluorinated surfaces that are nonwetting to organic materials,
which enables the fabrication of isolated objects with superior
shape and composition control but without harsh processing
steps (Figure 1). We have previously demonstrated that these
PFPE molds have superior replication properties for use in
lithographic applications in the microelectronics industry,
including sub-50 nm lateral resolution, clean surface release,
and precise control over replication morphology.22 Unlike other
mat rials, such as poly(di ethylsiloxane) (PDMS), PFPE-based
molds are both nonwetting and nonswelling to both inorganic
and organic materials.23 Though PRINT is akin to other soft
lithographic molding methods, it is unique because it pro uces
isolated particles instead of embossed films. This is especially
important as one gets to nanometer size ranges because the
dimensions of the desire objects approach the dimensions of
the residual film, typically called a “scum layer” or “flash
layer”.16-19 Other soft lithographic molding techniques typically
produce scum layers because the material to be molded has
(22) Rolland, J. P.; Hagberg, E. C.; Denison, G. M.; Carter, K. R.; DeSimone,
J. M. Angew. Chem., Int. Ed. 2004, 43, 5796-5799.
(23) Rolland, J. P.; Van Dam, R. M.; Schorzman, D. A.; Quake, S. R.; DeSimone,
J. M. J. Am. Chem. Soc. 2004, 126, 8349-8349.
Figure 1. Illustration of the PRINT process compared to traditional imprint lithography in which the affinity of the liquid precursor for the surface results
in a scum layer. In PRINT, the nonwetting nature of fluorinated materials and surfaces (shown in green) confines the liquid precursor inside the features of
the mold, allowing for the generation of isolated particles.
Fabrication and Harvesting of Nanobiomaterials A R T I C L E S
J. AM. CHEM. SOC. 9 VOL. 127, NO. 28, 2005 10097
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4.2.2. Hydrogel Template Method 
A novel method for synthesizing homogenous polymer particles was recently 
reported by the Park group (Acharya et al., 2010a, Acharya et al., 2010b). This method 
relies on the use of a hydrogel template made of a material such as gelatin (Acharya et 
al., 2010a). These gelatin templates can be easily constructed using common 
microfabrication techniques. They are mechanically stable enough to act as a mold yet 
undergo a sol-gel transition upon heating, allowing dissolution of the mold after particle 
formation is complete (Acharya et al., 2010a). This process can be used to make polymer 
particles from 200 nm to larger than 50 µm. The hydrogel template process is 
summarized in Figure 4.4.  
 
Figure 4.4. The hydrogel template method for particle synthesis. [A] A silicone wafer 
master is created with vertical posts of desired particle size. [B] A warm aqueous gelatin 
solution is poured on top of the master. [C] The gelatin is cooled to solidify and peeled 
off the master to expose cavities. [D] Cavities are filled with polymer mixture and dried 
to remove organic solvent. [E] Mold is dissolved in warm H2O, and particles are 
collected by centrifugation or filtration. From (Acharya et al., 2010a).  
An initial study examined the versatility of the synthesis method by fabricating 
poly(lactic-co-glycolic)acid (PLGA) particles of various sizes (from 200 nm up to 50 µm) 
and of various shapes, as shown in Figure 4.5 (Acharya et al., 2010a).  
Author's e sonal copy
in large quantities in a reproducible manner by simple microfabrication
processing steps. Thus, it is desirable to develop a method that can
collect formed particles by simply dissolving the t mplates in aqueous
solutions. It would be even more desirable if the drug-containing
particles can be delivered while they are still in the templates. For this
reason, a hydrogel systemthat canbe fully dissolved in queous solution
was contemplated. It was not clear, however, whether this approach
would be feasible, because it is well known that hydrogels, especially
sol–gel phase reversible hydrogels, do not have a mechanical strength
high enough tobeused as templates, and the condition for sol–gel phase
transition can be too harsh for loaded drugs. It was unexpectedly found,
however, that gelatin could be manipulated to possess a mechanical
strength sufficiently high enough for use as templates with a gel-to-sol
transition temperature low enough not to adversely affect the loaded
drugs.
Fig. 1 shows the main idea of the hydrogel template approach. The
first step is to form a pattern of vertical posts on a silicon wafer master
template (Fig. 1A). If an intermediary silicone rubber template is to
be used, then the vertical posts on the master template will become
vertical cavities. On top of the master template is poured a warm
aqueous gelatin solution, and then the temperature is lowered to
form a gelatin hydrogel imprint (Fig. 1B). Once the gelatin layer is
solidified, the gelatin mold is peeled off and the gelatin mold is
placed on the flat surface to expose the cavities (Fig. 1C). The cavities
in the gelatin mold are filled with a solution or a paste of drug/
polymermixture (Fig. 1D). In this study, poly(lactic-co-glycolic acid)
(PLGA) was used as a model biodegradable polymer, and Nile Red, a
fluorescent probe, was used for easy visualization unless specified
otherwise. The organic solvent present inside the cavities is removed
by drying, and the formed particles are collected by simply
dissolving the hydrogel mold, followed by centrifugation or filtration
(Fig. 1E).
3. Materials and methods
3.1. Materials
Gelatin (from porcine skin, Type A, 300 bloom), 1,6-diphenyl-
1,3,5-hexatriene (DPH), 6-propionyl-2-dimethylaminonaphthalene
(Prodan), and Nile Red were purchased from Sigma (St. Louis, MO,
USA), and poly(lactic-co-glycolic acid) (PLGA) of different molecular
weights (MW 36,000, IV 0.7 dL/g; MW 65,000, IV 0.82 dL/g; MW
112,000, IV 1.3 dL/g) were purchased from Lactel (Pelham, AL).
3.2. Fabrication of a silicon wafer master template by photolithography
A silicon wafer was spin coated with SU8 2010 photoresist
(Microchem, MA) at 3500 rpm for 30 s followed by baking at 95 °C
for 3 min. The photoresist coated silicon wafer was exposed to UV
radiation through a mask containing a 10 µm diameter circular
pattern for 12 s. Please note that the diameter can be changed to any
other value of interest, and any specific sizes used in this article are
just for a demonstration purpose. After exposure, the silicon wafer
was post baked at 95 °C for 3 min followed by development in SU-
8 developer for 2 min. The silicon wafer was rinsed with isopropanol
and dried with nitrogen gas. The wafer thus fabricated contained
10 µm diameter wells.
3.3. Fabrication of silicon master templates by electron beam (e-beam)
lithography
Making surface patterns of submicron sizes requires e-beam
lithography. Circular patterns of 500 nm squares were designed using
theAutoCAD2007program. A3-in. diameter siliconwafer coveredwith
1 µm thick SiO2 layer (University Wafer, South Boston, MA) was spin
coated with poly(methyl methacrylate) (PMMA, Microchem, Newton,
MA) photoresist of 300 nm thick layer using a spin coated at 3500 rpm
for 30 s (SCS P6708 spin coating system, Indianapolis, IN). The coated
PMMA photoresist layer was exposed to e-beam in a preprogrammed
pattern using a Leica VB6 High Resolution Ultrawide field e-beam
lithography Instrument (Bannockburn, IL) operating at 100 KV,
transmission rate 25 MHz current 5 nA. After e-beam lithography, the
silicon wafer was developed in 3:1 isopropanol:methyl isobutyl ketone
solution to remove exposed regions of the photoresist. A 5 nm thick
chromium layer and a 20 nm thick gold layer were successively
deposited on to this pattern followed by liftoff of the residual PMMA
film in refluxing acetone. The pattern was transferred to the underlying
silicon oxide by deep reactive ion etching with SF6/O2 plasma. The
generated silicon master template was used in the fabrication of
hydrogel templates.
3.4. Fabrication of hydrogel templates
A clear gelatin solution (30% w/v in aqueous solution, 10 ml) at
50–55 °C was transferred with a pipette onto a silicon master
template (3in. diameter) containing circular pillars (e.g., of 10 μm
diameter and 10 μmheight). The gelatin solutionwas evenly spread to
form a thin film completely covering the master template and cooled
to 4 °C for 5 min by keeping it in a refrigerator. Cooling resulted in
formation of a gelatin template which was subsequently peeled away
from the master template. The obtained gelatin template was ∼3in. in
diameter, and contained circular wells (e.g., of 10 μm diameter and
10 μmdepth). The gelatin template was examined under a bright field
reflectance microscope to determine its structural integrity. The
preliminary experiment suggested that a solution of 30% gelatin
resulted in templates which were elastic and mechanically strong
enough for further processing.
3.5. Polymeric microstructures
200 μl of 40% PLGA solution (MW112,000, IV 1.3 dL/g)w/v in CH2Cl2
doped with Nile Red was transferred with a pipette onto a gelatin
template containing circular trenches of, e.g., 10 μmdiameter anddepth.
The PLGA solution was evenly spread. The PLGA-filled gelatin template
was left to dry at room temperature (∼25 °C) for 5–10 min. The gelatin
template filledwith PLGA solutionwas characterized by bright field and
fluorescence microscopy.
3.6. Collection of free microstructures
Gelatin templates filled with PLGA solution were left at room
temperature for 10 min to remove most of CH2Cl2 solvent from the
templates. For complete removal of the solvent, extended drying at
elevated temperatures or freezedrying canbeused. Abatchof 10gelatin
templates were dissolved in a 100 ml beaker containing 50 ml of
Nanopure water at 40 °C and gently shaken for 2 min to completely
dissolve the templates. This step resulted in complete release of the
free and isolated microstructures into the solution. The dispersion
was transferred into conical tubes (15 ml) and centrifuged for 5 min
(Eppendorf Centrifuge 5804, Rotor A-4-44, at 5000 rpm, 19.1 RCF,
Fig. 1. Schematic description of the hydrogel template approach for fabrication of
homogeneous microstructures. See text for descriptions of steps A–E.
315G. Acharya et al. / Journal of Controlled Release 141 (2010) 314–319
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Figure 4.5. Various shapes of particles synthesized from the hydrogel template 
method. Particle size is 50 µm. From (Acharya et al., 2010a). 
A further study by Acharya et al. analyzed drug release from degrading PLGA 
microparticles (Acharya et al., 2010b). These particles displayed extremely high drug 
loading capabilities (>50% wdrug/wPLGA) and delivered ~80-100% of loaded drug within 
20-25 days. Release kinetics were dependent on surface area, diffusion coefficient, and 
concentration gradient (Acharya et al., 2010b).  
4.3. Materials and Methods 
All reagents were purchased from Sigma-Aldrich and used as received, unless 
otherwise noted. Polydimethylsiloxane (PDMS) templates were received from Dr. 
Ghanashyam Acharya from The Methodist Hospital Research Institute. All water used in 
synthesis, purification, and testing was treated by a Milli-Q system (≥18.0 MΩ.cm 
resistivity). 
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structures on their biological behavior, such as blood circulation times,
targeting, and cellul r internalization for intravenous administration of
submicron sizes [16,17]. But the effect of the shape on biological
response has not been fully examined, mainly due to the lack of
availability of suchparticulate systems. Traditional emulsionmethodsof
preparing nano/microparticles result in spherical shape, and only
recently, formation of particles in a variety of different geometries
became p ssible as a result of dvances in nano/microfa rication
techniques. Microstructures with complex geometries influence the
anisotropic interactions with biomolecules through steric or spatially
segreg ted surface functionalities. Phagocytosis by macrophages and
the renal and hepatic clearance of microstructures are also known to be
influenced by the geometry of nano/microstructures [18].
It will be useful to g n r te a comprehensive library of micro-
structures with complex geometries to examine their potential benefits
of targeted drug delivery. Figs. 2 and 3 show formation of disc shape
particles, and Figs. 4 and 5 show he capabilit of making micro-
structures with almost any geometry. Furthermore, the hydrogel
template approach can also be used to prepare multi(n)-layered
microstructures by simply filling the cavities of the template n times.
Thus, the same drug can be loaded at different concentrations or
different drugs canbe loaded into the sameparticles. Suchmulti-layered
structures are useful in making even more advanced structures, e.g.,
capsules, for delivery of fragile drugs, such as peptide and protein drugs,
and in making multi-functional systems. The ease and flexibility of the
hydrogel template approach are expected to find applications in
delivery of diverse drugs, ranging from low molecular weight
hydrophobic drugs to high molecular weight proteins. The hydrogel
template approach provides a newoption of fabricatingmicrostructures
with various geometries and with multi-functional systems.
6. Conclusions
A hydrogel template approach was developed to prepare homo-
geneous nano/micro structures of various geometries. This can be
readily applicable for the large scale production of nano/microparti-
cles because of its easiness in producing particles. The flexibility in
forming different microstructures allows the approach to incorporate
diverse drugs with various hydrophilic characters and molecular
weights. The study demonstrated production of particles in various
geometries and sizes with high precision. Drug loading is also shown to
be very high with controllable drug release kinetics. The hydrogel
template approach provides a new avenue of preparing nano/micro-
particles for drug delivery.
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4.3.1.  Synthesis of PDMS Templates 
PDMS templates were synthesized analogously to methods described previously 
(Acharya et al., 2010a, Lu et al., 2014). Briefly, a photoresist was spun-coated to a height 
of 500 nm and baked. The photoresist was then exposed using E-beam lithography in a 
predetermined pattern consisting of an array of circular features 500 nm in diameter. 
Thus, a master was created consisting of an array of wells of a 500 nm diameter and 
height. This master template was then coated with Sylgard 184 elastomer (Dow Corning) 
and cured for 2 hr at 70 oC. The PDMS template was then carefully removed from the 
master template, yielding a template consisting of cylindrical features 500 nm in diameter 
and height.  
4.3.2. Synthesis of Hydrogel Templates 
The hydrogel template method described in Section 4.1.2 was used to synthesize 
500 nm poly(NIPAAm-co-AAm) hydrogels with embedded nanoshells. The PDMS 
templates used contained 500 nm cylindrical (i.e., 500 nm in diameter and 500 nm in 
height) vertical posts, with each 2-inch square template containing an array of 5 x 108 
posts. Next, 4 ml of a warmed (50-55 oC) 20% w/v aqueous Gelatin Type A solution was 
poured over the PDMS template. After allowing the gelatin to solidify by incubating at 4 
oC for 15 min, the gelatin was peeled from the PDMS template, revealing a second 
template with circular wells of 500 nm diameter and 500 nm height.  
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4.3.3. Hydrogel Template Particle (HTP) Synthesis  
After template synthesis, a monomer solution containing NIPAAm, AAm, and 
MBAAm in H2O was made analogously to that made Section 2.1.2 (1.56 M NIPAAm, 82 
mM AAm, and 2.18 mM MBAAm in H2O). In addition, gold-silica nanoshells were 
added to this solution at a concentration of 1.5 x 1010 particles/ml, as at this concentration 
it was estimated that 1.5 nanoshells would be loaded in each well of the template.  
Aliquots of 100 µl were made of this monomer suspension, and polymerization was then 
initiated by addition of 2.5 µl APS (10% w/v in H2O) and 0.5 µl TEMED. After rapid 
mixing by vortexing, 50 µl of this solution was pipetted onto a gelatin template and 
whisked across using a razor blade at a 45o angle to completely fill the template wells. 
The particles were allowed to polymerize for 2 hr at room temperature. 
After polymerization, hydrogel templates were dissolved in H2O (with 0.1% w/v 
NaN3 to prevent microbial contamination) and incubated at 50-55oC for 30-60 min. The 
hydrogel-nanoshell composite particles (HNCPs) were then purified by 2 rounds of 
centrifugation (2000 x g, 5 min) and then passed through a 5 µm polycarbonate 
membrane filter. Poly(NIPAAm-co-AAm) hydrogel particles without nanoshells (NHPs) 
were synthesized analogously without adding nanoshells to the monomer solution. A 
schematic of this process is shown in Figure 4.6.  
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Figure 4.6. Particle synthesis based on hydrogel template method. [1] Master created 
with cylindrical posts 500 nm (diameter) by 500 nm (height). [2] Warm gelatin poured 
over master. [3] Cooled gelatin peeled off of master to reveal cavities 500 nm (diameter) 
by 500 nm (height). [4] Monomer solution and gold-silica nanoshells poured into 
cavities. Polymerization is initiated by APS/TEMED. [5] After polymerization, gelatin 
template is dissolved in warm water and HNCPs are collected by centrifugation.  
4.3.4. Hydrogel Template Particle (HTP) Characterization  
After synthesis, HNCPs were characterized using electron microscopy. A FEI 
Tecnai G2 Twin TEM was used for visual inspection of the poly(NIPAAm-co-AAm) 
polymer as well as any embedded gold nanoshells. 
DLS was used to determine changes in particle size in response to increased 
temperatures and NIR irradiation. DLS measures the Brownian motion of particles in a 
liquid to extrapolate their hydrodynamic radius (Malvern Instruments, 2014). Both 
HNCPs and NHPs were sized using a Brookhaven 90-Plus Particle Size Analyzer under 
three different conditions: at 25 oC, at 50 oC, and after being exposed to NIR irradiation 
(808 nm, 5 W/cm2, 5 min). For the NHPs, the refractive index of poly(NIPAAm) was 
used (1.52) (Reufer et al., 2009). For the HNCPs, the refractive index of gold at 660 nm 
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(the incidence of the detection laser) was used (0.169 + 3.821i) (Schulz and Tangherlini, 
1954, Schulz, 1954). Hydrodynamic diameters at 25 oC, 50 oC, and post NIR irradiation 
were compared using an ANOVA with Tukey’s HSD. 
4.4. Results 
4.4.1. TEM Characterization  
TEM images of gold-silica nanoshells and HNCPs are compared in Figure 4.7, 
indicating that the HNCPs having a thin polymer coating around the gold nanoshells. 
Since samples must be fully dehydrated before imaging, this coating is much smaller than 
it would be in its hydrated state. 
 
Figure 4.7. Analysis of HTPs by TEM. [A] TEM image of an HNCP compared to [C] 
TEM images of a bare nanoshell. Scale bar = 30 nm. [B] Higher magnification of this 
coating as compared to [D] the bare nanoshell surface. Scale bar = 10 nm. 
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4.4.2. Thermal Analysis via Dynamic Light Scattering 
Changes in the hydrated sizes of both HNCPs and NHPs in response to increased 
temperatures as well as NIR irradiation was analyzed using DLS, with results 
summarized in Figure 4.8. NHPs have a significantly smaller diameter when incubated at 
50 oC, while the HNCPS have a significantly smaller diameter when either incubated at 
50 oC or exposed to NIR irradiation (as determined by ANOVA with Tukey’s post hoc 
test, n=3). 
 
Figure 4.8. Analysis of HNCP thermal deswelling. Hydrodynamic diameters of 
hydrogel-only and hydrogel-nanoshell composite particles as measured by DLS. 
Measurements are normalized to particle size at 25oC. Hydrogel-only particles deswell in 
response to increased temperature, while hydrogel-nanoshell particles deswell in response 
to either increased temperature or exposure to NIR irradiation. (*p<0.05, **p<0.01).  
While DLS provides a technique to determine the size of sub-micron particles in a 
hydrated state, the measurements are dependent on many factors, including the material 
refractive index (Malvern Instruments, 2014), and the HNCPs consist of two different 
materials with drastically different refractive indices. In addition, DLS measurements 
assume particles are spherical, whereas these particles are cylindrical (Malvern 
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Instruments, 2014). Due to these limitations, the hydrodynamic diameters measured are 
most likely not the particle’s true size, so measurements for each particle type are 
normalized to its measurement at 25 oC. 
Additionally, when the particle sizes of the HNCPs in the collapsed state were 
measured, two separate size populations emerged, as displayed in Figure 4.9. A 
population at a smaller diameter represented single particles, while a second population 
centered around a larger diameter likely resulted from the aggregation of multiple 
particles.  The material phase transition that causes polymer collapse will also act as a 
driving force for aggregation due to the hydrophobic effect. For the data displayed in 
Figure 4.8, only the “single particle population” of these measurements was used.  
 
Figure 4.9. Typical size distribution of HNCPs in their collapsed stage after 
irradiation. The particles exhibited two distinct populations, hypothesized to be single 
particles vs. particle aggregates.   
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4.5. Discussion and Conclusions 
In this chapter, the composite material developed in Chapters 2-3 of this 
dissertation was synthesized as nanoscale particles by using a dissolvable gelatin 
template. Image analysis using TEM indicates that the resulting particles consist of a 
nanoshell core surrounded by thin polymer layer. The hydrodynamic diameter of these 
particles decreases in response to either incubation at 50 oC or exposure to NIR 
irradiation, proving that these particles retain the same thermal properties as the bulk 
material. This indicates the potential of this material to be used as an injectable-sized 
platform for therapeutic delivery.  
One potential disadvantage of using this synthesis method is that it does not allow 
for direct control over how many nanoshells are loaded into each well of the gelatin 
template, and therefore how many nanoshells are in each HNCP. While each template 
was loaded with a nanoshell concentration corresponding to ~1.5 nanoshells/well, this 
will result in an HNCP population with a distribution of loaded nanoshells, with zero, 
one, or even two or more nanoshells per composite particle. This distribution may also be 
contributing to the heterogeneity of the DLS measurements, where often multiple size 
populations could be detected.  
For this delivery platform, a 1:1 ratio of hydrogel:nanoshell would allow for 
maximal volume for drug loading (due to only having one nanoshell per particle) with 
each composite particle maintaining its NIR nanoshell trigger. To achieve such, a second 
synthesis method in which a hydrogel network is grown off of individual nanoshells, 
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therefore resulting in this 1:1 ratio, was explored. This method will be described in the 
next two chapters of this dissertation.  
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5. Hydrogel Coated Nanoshells: Synthesis Using 
Surface Initiated- Atom Transfer Radical 
Polymerization 
In addition to the molding techniques discussed in Chapter 4, controlled radical 
polymerization (CRP) methods have been researched for the synthesis of near-
monodisperse polymer nanoparticles. These methods allow for tight control over the 
spatial location of generated free radicals, thus resulting in desirable polymer properties 
such as high control over molecular weights and end functionalities (Coessens et al., 
2001). Several different types of CRP techniques have been investigated for synthesizing 
thermally-responsive hydrogel coatings onto individual particles including reversible 
addition-fragmentation chain transfer (RAFT) (Shan et al., 2004, Shan et al., 2005, 
Nupponen and Tenhu, 2007, Yusa et al., 2007), surfactant-free emulsion polymerization 
(SFEP) (Kim and Lee, 2006, Kim and Lee, 2007, Kim and Lee, 2008), surface initiated-
atom transfer radical polymerization (SI-ATRP) (Frimpong and Hilt, 2008, Wei et al., 
2008, Chakraborty et al., 2010, Chirra et al., 2012), and other methods (Morones and 
Frey, 2009, Singh and Lyon, 2007). These techniques are summarized in Table 5.1 
below. Additional studies have focused on the investigation of aerosol-based fabrication 
of poly(NIPAAm)-metal nanoparticle composites (Byeon and Roberts, 2012), and 
synthesis of poly(NIPAAm)-based hydrogels and gold nanoparticles simultaneously 
yielding uniform nanoscale composites (Zhu et al., 2012).   
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Table 5.1. Radical Chain Polymerization Techniques (Odian, 2004, Barner-Kowollik 
et al., 2001, Xu et al., 2009). 
Surfactant-Free Emulsion 
Polymerization (SFEP) 
 
-Initiator soluble in aqueous 
phase 
 
-Produces free radicals that are 
surface-active of polymer 
particles 
 
-Polymerization occurs on 
surface of polymer droplets in oil 
phase 
 
Reverse-Addition 
Fragmentation Polymerization 
(RAFT) 
 
-Requires initiator in presence of 
chain-transfer agent  
 
-Living polymerization technique 
 
Atom Transfer Radical 
Polymerization (ARTP) 
 
-Requires a transition metal 
catalyst, nitrogen based ligand, 
and alkyl-halide 
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M
+
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2
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M = Transition Metal
L = Nitrogen-based Ligand
X = Br or Cl
 87 
5.1. Controlled Polymerization of Poly(NIPAAm) 
5.1.1. Surfactant-Free Emulsion Polymerization 
The work of Kim et al. investigated SFEP of poly(NIPAAm-co-AAc) onto gold 
nanoparticles and gold-silica nanoshells for drug delivery applications (Kim and Lee, 
2006, Kim and Lee, 2007, Kim and Lee, 2008).  This synthesis method used a 94:6 wt% 
ratio of NIPAAm:AAc and MBAAm as a crosslinking agent. This process was carried 
out on 60 nm gold nanoparticles (Kim and Lee, 2006) and 120 nm gold-silica nanoshells 
(Kim and Lee, 2008). In addition, studies using SFEP poly(NIPAAm-co-AAc) as a 
template for the growth of large (60-150nm) gold nanoparticles have also been 
investigated (Kim and Lee, 2007). In the study utilizing gold-silica nanoshells, field 
emission scanning electron microscopy (FE-SEM) images showed uniform particle sizes 
as well as contrast effects showing particle cores with a complete hydrogel coating (Kim 
and Lee, 2008). Energy-dispersive X-ray spectroscopy (EDX) analysis showed large 
peaks indicating gold atoms as well as no peaks for the hydrogel polymer, as predicted 
given the low atomic numbers of the hydrogel elements. Higher resolution TEM images 
show the complete hydrogel shell growth around the particle, as well as differences in 
hydrogel thickness that could be obtained by minor variations in the monomer and 
initiator amounts or reaction time. UV-Vis spectroscopy showed minimal changes in the 
absorption profile of the bare gold-silica nanoshells and hydrogel-coated nanoshells. DLS 
studies show that the hydrodynamic radius of the hydrogel particles decreasing with 
increasing temperature, an indication of collapse of the hydrogel (Kim and Lee, 2008). 
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However, one drawback of this polymerization method is the encapsulation of multiple 
particles into one hydrogel matrix. The results of this study are summarized in Figure 4.2. 
 
Figure 5.1. Hydrogel coating by surfactant-free emulsion polymerization (SFEP). 
[A] TEM images of (a) bare nanoshells (diameter~120 nm); (b) thin hydrogel-coated 
nanoshells (diamter~160 nm); (c) thick hydrogel-coated nanoshells; and (d) multiple 
encapsulated nanoshells. [B] UV-Vis spectra of gold-seeded silica cores, bare nanoshells, 
and hydrogel coated nanoshells. [C] Hydrodynamic diameters of bare nanoshells and 
hydrogel-coated nanoshells as a function of temperature. Adapted from (Kim and Lee, 
2008). 
5.1.2. Surface-Initiated Atom Transfer Radical Polymerization 
Controlled radical polymerization methods such as RAFT, SFEP, and ATRP 
primarily differ in their method of radical generation. In ATRP, free radical generation 
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stems from an organic halide undergoing a reversible redox process catalyzed by a 
transition metal compound, commonly a cuprous halide (Odian, 2004, Xu et al., 2009). 
The ATRP process is described below in Equations 5.1-5.3: 
   Equation. 5.1  
                                                                                    
 
                                                                                                                                                                  Equation. 5.2   
                                                                              
                                                                                                                                                                                                                          
   Equation. 5.3   
where L is a complexing ligand that helps solubilize the CuBr catalyst in the organic 
reaction system; ka and kd are rate constants for activation and deactivation of the halide 
initiator; CuBr  is the catalyst which undergoes an electron transfer to generate a free 
radical, R., which then serves to initiate polymerization; M is the monomer; and 
R Br + CuBr(L)
ka
kd
R + CuBr2(L)
M
RMn
CuBr2(L)
RMn-Br + CuBr(L)
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CuBr2(L) is the persistent (metallo)radical that reduces the steady-state concentration of 
propagating radicals and minimizes normal termination of living polymers (Odian, 2004). 
ATRP is capable of producing well-defined polymers with low polydispersities 
(Mw/Mn<1.3), causing it be utilized in applications requiring precisely controlled 
polymerization (Coessens et al., 2001). This control is based on two principles: (1) 
initiation should be fast in order to provide a constant concentration of growing polymer 
chains, and (2) the majority of dormant polymer chains should retain the ability to grow 
due to the dynamic equilibrium between the dormant species and growing radicals (Xu et 
al., 2009).  When the concentration of propagating radicals is low compared to dormant 
species, as is seen throughout most of the polymerization process, termination processes 
are suppressed, allowing for uniformity of polymer growth (Xu et al., 2009). Another 
advantage is this synthesis allows for mild polymerization conditions; one study by Xia et 
al. finds that poly(NIPAAm) with a polydispersity of 1.1-1.2 and degree of 
polymerization of up to 300 can be achieved at room temperature in solvents such as 2-
propanol or tert-butyl alcohol (Xia et al., 2005).  
Additionally, if the organic halide initiator can be immobilized onto a substrate, 
polymers can be grafted from the substrate to yield a uniform surface coverage (Xu et al., 
2009).  Several ATRP initiators have been modified with functional groups to allow for 
immobilization on various surfaces, including silane-containing initiators for 
immobilization on silica based surfaces and thiol-containing initiators for immobilization 
on gold surfaces. In this process, know as surface initiated- atom transfer radical 
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polymerization (SI-ATRP) polymer growth can be controlled to occur only at distinct 
spatial locations where the initiator has been immobilized.  
Poly(methyl methacrylate) (PMMA) was the first polymer to be synthesized using 
surface initiated-atom transfer radical polymerization (Edmondson et al., 2004). In this 
1998 study, Ejaz et al. immobilized the ATRP initiator 2-(4-chlorosulfonylpenyl) ethyl 
trimethoxysiline onto an oxidized silicon substrate using the Langmuir-Blodgett (LB) 
technique and then grew PMMA chains off these sites (Ejaz et al., 1998). Masci et al. 
reported the first successful polymerization of poly(NIPAAm) using ATRP and mild 
reaction conditions (room temperature with N,N-dimethylformamide [DMF] as the 
solvent) (Masci et al., 2004).   
The formation of poly(NIPAAm)-based polymer brushes off of various surfaces 
has been widely researched and reported (Edmondson et al., 2004, Wei et al., 2008, 
Chakraborty et al., 2010, Vasani et al., 2011, Shivapooja et al., 2012). However, 
synthesis of crosslinked hydrogel networks using SI-ATRP has been considerably less 
explored (Chirra and Hilt, 2010).  A brief discussion of previous instances of 
poly(NIPAAm)-based hydrogel synthesis via SI-ATRP follows.   
5.1.2.1. SI-ATRP of Poly(NIPAAm)-Based Hydrogels on 2D Surfaces 
In a recent study by Chirra et al., microcontact printing (µCP) was used to pattern 
areas of an ATRP initiator (bromoisobutyrate-terminated undecyl disulfide) onto gold 
films (Chirra et al., 2009). From this, a poly(NIPAAm) hydrogel crosslinked by various 
(ethylene glycol)-dimethacrylate based molecules were grown. The combination of µCP 
and ATRP allowed for tight control of polymer growth in both the XY (µCP) and Z 
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(ATRP) directions. Analysis via atomic force microscopy (AFM) showed that increasing 
reaction times increased the overall thickness of the poly(NIPAAm) hydrogel, as shown 
in Figure 5.2.  
 
Figure 5.2. Normalized AFM images of poly(NIPAAm) hydrogels crosslinked with 
ethylene glycol dimethacrylate (EGDMA) (a-c), PEG-200-dimethacyrlate (70:30 
mol%) (d-f), and PEG-400-dimethacrylate (90:10 mol%) (g-i). Each pattern is 25 µm 
long. The EGDMA gels were synthesized for (a) 25 hr, (b) 36 hr, and (c) 48 hr; the 
PEG200DMA gels for (d) 5 hr, (e) 16 hr and (f) 20 hr; and the PEG400DMA gels for (g) 
4.5 hr, (h) 16 hr and (i) 36 hr. From (Chirra et al., 2009). 
Further analysis of this system looked at the thermal response of these surface 
patterned hydrogels (Chirra and Hilt, 2010). As shown in Figure 5.3, increasing the 
temperature of these patterns decreased the pattern thickness (as measured by AFM). 
Additionally, hydrogel thickness is also dependent on crosslinking density with lower 
density and larger crosslinking molecules (PEG600DMA vs PEG400DMA) allowing for 
 93 
an increased mesh size of the hydrogel, and therefore increased swelling ability and 
increased thickness (Chirra and Hilt, 2010).  
 
Figure 5.3. Hydrogel thickness (as determined by AFM) at solution temperatures. In 
addition, amount and type of crosslinker employed also has a large effect on hydrogel 
thickness. From (Chirra and Hilt, 2010). 
5.1.2.2. SI-ATRP of Poly(NIPAAm)-Based Hydrogels on 3D Surfaces (Particle 
Coatings) 
Synthesis of hydrogel coatings using SI-ATRP has also been investigated as tight 
control of hydrogel thickness can be achieved, providing for monodisperse particles. Wei 
et al. used this method to create a poly(NIPAAm) coating on NIR absorbing gold 
nanorods (Wei et al., 2008). This study used gold nanorods with an aspect ratio of 
4.4±0.4 and a peak longitudinal plasmon resonance at 843 nm. A disulfide-containing 
initiator was immobilized onto the gold nanorod surface followed by in situ 
polymerization of poly(NIPAAm). TEM characterization of the particles indicated a 
core/shell structure was formed, and it was noted that the thickness of the coating could 
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be tuned by the polarity of the solvent, with more polar solvents yielding thicker coatings. 
DLS showed an increase in hydrodynamic diameter at temperatures from 32-37oC, 
indicating the hydrogel coatings had collapsed and become more hydrophobic, causing 
the particles to precipitate out of solution and aggregate.  In addition, a drug loading 
experiment with the antibiotic norvancomycin showed increased release when the 
particles were irradiated with an 808 nm laser (Wei et al., 2008).  
This method has also been employed using iron oxide nanoparticles. Frimpong et 
al. demonstrated growth of a PNIPAAm hydrogel with poly(ethylene glycol) 400 
dimethacrylate (PEG400DMA) crosslinks using SI-ATRP on iron oxide particles of 6-10 
nm diameters (Frimpong and Hilt, 2008). First, particles coated with either oleic acid or 
citric acid underwent a ligand exchange reaction to coat the surface in bromide-
containing initiator molecules. Next, an ATRP reaction was carried out to form a 
poly(NIPAAm-PEG400DMA) coating. High-resolution TEM analysis indicated the 
resulting particles consist of an ordered crystalline core next to an amorphous polymer 
shell less than 5 nm thick. DLS analysis showed larger hydrodynamic diameters of these 
particles at temperatures at 20-30 oC, while smaller hydrodynamic diameters were 
observed at temperatures above the hydrogel LCST (Frimpong and Hilt, 2008).   
Similar studies synthesizing hydrogel coatings via SI-ATRP have also been 
reported (Li et al., 2004, Li et al., 2007, Dong et al., 2008), however aggregation issues 
due to interparticle interactions during the growth of the hydrogel coatings and multiple 
processing steps often lead to low yields (Li et al., 2007, Chirra et al., 2012). To remedy 
this, Chirra et al. proposed a novel solution in which gold nanoparticles are first stabilized 
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in a flexible hydrogel matrix prior to initiator immobilization and polymer growth (Chirra 
et al., 2012). This scheme, named “Isolate, functionalize, and release” or “ISOFURE”, is 
summarized in Figure 5.4. This ISOFURE scheme served as an inspiration for the 
synthesis process described in this chapter.  
 
Figure 5.4. Schematic of ISOFURE. Gold nanoparticles are first encapsulated in a 
hydrolytically degradable poly(ethylene glycol diacrylate-co-isobutyl amine) hydrogel. 
The hydrogel network is then swelled, allowing initiator assembly and ATRP of a 
poly(NIPAAm)-based hydrogel coated to take place within the network. After 
polymerization, the poly(ethylene glycol diacrylate-co-isobutyl amine) matrix is 
degraded via hydrolysis and the poly(NIPAAm)-coated gold nanoparticles are collected. 
From (Chirra et al., 2012). 
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5.2. Materials and Methods 
All reagents were purchased from Sigma-Aldrich and used as received, unless 
otherwise noted. All water used in synthesis, purification, and testing was treated by a 
Milli-Q system (≥18.0 MΩ.cm resistivity). 
In the ISOFURE method described previously, the sacrificial matrix was 
poly(ethylene glycol diacrylate-co-isobutyl amine). This hydrogel was synthesized using 
free radical polymerization requiring the addition of chemical initiators (APS and 
TEMED). Additionally, while this matrix was hydrolytically degradable, degradation was 
a slow process that took up to 72 hr (Chirra et al., 2012).  For these reasons, a Ca2+-
alginate hydrogel was chosen for the sacrificial matrix, which allows for milder 
crosslinking conditions and a faster reversal of gelation.  
Alginate is a water-soluble polysaccharide consisting of mannuronic and 
guluronic acid residues (Figure 5.5A). Alginate is widely available commercially, 
commonly extracted from species of brown algae and packed as a salt with cations such 
as Na+. If two gluruonic acid residues are aligned side by side, a hole emerges which is 
the ideal for cooperative binding of calcium ions (George and Abraham, 2006). Gelation 
and crosslinking of alginate occurs in the presence of a divalent cation such as Ca2+, 
where the Ca2+ displaces the sodium ions associated with the gluruonic acid residues. 
This in turn induces stacking of multiple gluruonic acid residues and physical 
crosslinking of multiple alginate chains (Figure 5.5B). The resulting material is a stable 
hydrogel that maintains its shape and resists stress (George and Abraham, 2006). 
 97 
 
Figure 5.5. Structure of Ca2+-alginate gels. [A] Chemical structure of alginate shown as 
two guluronic acid residues (G) and two mannuronic acid residues (M). [B] The addition 
of calcium ions causes cooperative binding of multiple gluruonic acid residues resulting 
in physical crosslinking of alginate chains into a stable hydrogel network. Adapted from 
(George and Abraham, 2006). 
Alginate hydrogels are commonly formed as “beads” by dripping a solution of 
sodium alginate into a solution containing calcium ions, commonly CaCl2 (Kuo and Ma, 
2001). Additionally, these hydrogels can be quickly degraded by the addition of a 
calcium-chelating agent, such as ethylenediaminetetraacetic acid (EDTA). These 
reactions are mild enough to be used to encapsulate and release cells (Bonaventure et al., 
1994). 
5.2.1. Ca2+-Alginate Encapsulation 
Gold-silica nanoshells were synthesized using the methods outlined in Chapter 2. 
Next, a 50 ml solution containing 1.5 wt% sodium alginate and nanoshells at an O.D. of 2 
(5.8 x 109 nanoshells/ml) was prepared in H2O. This solution was then added dropwise to 
100 ml of 1 wt% CaCl2 in H2O under rapid stirring. This resulted in the formation of 
many small Ca2+-alginate-nanoshell hydrogel “beads”. The reaction mixture was stirred 
for 15 min after which the Ca2+-alginate-nanoshell “beads” were collected by filtration 
and rinsed 3 times with H2O.  
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5.2.2. Initiator Immobilization 
Next, the initiator bis[2-(2’bromoisobutryloxy)ethyl]disulfide  (subsequently 
referred to as Br-initiator; ATRP solutions, Pittsburg, PA) was immobilized onto the 
surface of the gold-silica nanoshells via gold-thiol interactions. First, a 50 ml solution 
containing 20 mM Br-initiator and 10 mM tris(2-carboxyethyl)phosphine (TCEP) 
(Thermo Fisher Scientific) in 1:1 EtOH:H2O was incubated at RT for 60 min. This step 
serves to reduce the disulfide bond in the Br-initiator, resulting in two molecules with 
terminal thiol groups that can then assemble onto the gold-silica nanoshells through gold-
thiol interactions, as illustrated in Figure 5.6.   
For immobilization onto the gold-nanoshell surface, the Ca2+-alginate-nanoshell 
hydrogels were soaked in this Br-initiator/TCEP solution and rocked overnight at 4 oC. 
The next day, the gels were washed 3 times with EtOH followed by 3 times with H2O to 
remove any non-immobilized molecules.  
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Figure 5.6.  Immobilization of Br-initiator onto gold-silica nanoshells. The disulfide 
bond within the Br-initiator molecule is first reduced using TCEP, and the resulting 
molecules are then assembled onto the nanoshell surface via gold-thiol interactions.  
5.2.3. Polymerization using ATRP 
The Ca2+-alginate hydrogels containing the Br-initiator immobilized nanoshells 
were soaked in a 100 ml solution of 98:2 MeOH:H2O (v/v) in a three-neck round bottom 
flask. Under rapid stirring, the flask was evacuated and Ar gas was bubbled through the 
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solution for 30 minutes to remove dissolved O2. After 30 min, the ATRP reaction 
components described in Table 5.2 were added to the flask. For this polymerization 
reaction, the same 95:5 NIPAAm:AAm and 1:750 MBAAm:monomers ratios as have 
been previously described were used. The flask was again evacuated and Ar was bubbled 
for an additional 30 min. The reaction mixture was then stirred at 1000 rpm for 18 h. 
Table 5.2. ATRP reaction components. 
Component Concentration Purpose 
NIPAAm 23.75 mM Monomer 
AAm 1.25 mM Monomer 
MBAAm 0.0333 mM Crosslinker 
CuBr 0.2 mM Catalyst 
2,2’-bipryidine 0.6 mM Complexing ligand 
CuBr2 0.02 mM Persistent (metallo)radical 
After 18 h, the reaction was stopped by opening the flask to air. The Ca2+-alginate 
hydrogels were collected by filtration, and then rinsed 5 times with MeOH followed by 5 
rinses with H2O to remove any unreacted components.  
5.2.4. Dissolution of Ca2+-Alginate and Particle Collection 
After the ATRP reaction, the Ca2+-alginate hydrogel was dissolved and the 
encapsulated poly(NIPAAm-co-AAm)-coated gold nanoshells (NCNS) were collected. 
The Ca2+-alginate-nanoshell beads were soaked in 50 ml of 100 mM EDTA in TBS. This 
solution was vortexed for 1 min and then rocked at RT for 30 min to allow for sufficient 
chelation of the Ca2+ ions and dissolution of the Ca2+-alginate hydrogels. The NCNS 
were then collected via 2 rounds of centrifugation (735 x g, 15 min) and the solution was 
passed through a 5 µm polycarbonate membrane filter. This entire synthesis process is 
summarized in Figure 5.7. 
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Figure 5.7. Synthesis of NCNS via SI-ATRP. Nanoshells are first encapsulated in Ca2+-
alginate hydrogels. Within this hydrogel matrix, initiator immobilization onto the 
nanoshells and ATRP growth of poly(NIPAAm-co-AAm) is carried out. After 
polymerization is complete, the Ca2+-alginate is dissolved by the addition of EDTA and 
the NCNS are collected.  
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5.2.5. Particle Characterization 
Bare nanoshells, initiator-functionalized nanoshells, and NCNS were 
characterized using UV-Vis spectroscopy, DLS, zeta potential analysis, and TEM. 
Extinction spectra from 400-1000 nm were collected using a Cary 50 Varian 
spectrophotometer. DLS and zeta potential were measured using a Malvern Zetasizer 
Nano ZS. For DLS measurements, the refractive index of gold at 633 nm (the incidence 
of the detection laser) was used (0.2 + 3.32i) (Schulz and Tangherlini, 1954, Schulz, 
1954), and the Z-average size is reported. An FEI Tecnai G2 Twin was used for TEM 
imaging.  
5.2.6. Multiphoton Imaging of NCNS 
Since gold-silica nanoshells display two-photon induced photoluminescence (Park 
et al., 2008, Coughlin et al., 2014), multiphoton microscopy was employed to visualize 
the NCNS in their hydrated state. To visualize both the gold-silica nanoshell core and 
hydrogel coating simultaneously, a FITC-tagged dextran was soaked into the hydrogel 
coating.  
NCNS were pelleted and soaked in an aqueous solution containing 1 mg/ml 
FITC-dextran (3000 MW, Life Technologies) at 4 oC for 7 days. The particles were then 
purified by two rounds of centrifugation (735 x g, 15 min). Next, FITC-dextran loaded 
NCNS and non-loaded NCNS were encapsulated in poly(ethylene glycol diacrylate) 
(PEGDA) hydrogels to constrain passive particle movement during imaging. Particles 
were suspended in a 20 wt% solution of PEGDA (6 kDa) at an O.D. of 0.6 (1.4 x 109 
particles/ml). A photoinitiator solution was prepared containing 2,2-dimethyoxy-2-
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phenylacetophenone in N-vinylpyrrolidone at a concentration of 300 mg/ml. Next, 2 µl of 
this photoinitiator solution was added to 100 µl of the PEDGA-NCNS suspension and 
exposed to UV light for 60 s to allow for crosslinking of a PEGDA network with 
encapsulated NCNS.  
NCNS with and without FITC-dextran were then imaged using an Olympus 
FV1000 Multiphoton microscope with a Chameleon femtosecond Ti:Saph laser  
(Coherent, 680-1080 nm). The gold-silica nanoshells were imaged by exposure at 810 nm 
and collection from 575-630 nm, while signal from the FITC-dextran was imaged by 
exposure at 920 nm and collection from 495-540 nm.  
5.2.7. Thermal Deswelling Analysis 
DLS measurements were used to investigate changes in particle size in response 
to increased temperatures as well as NIR irradiation. Measurements were taken at various 
temperatures (25 oC, 37 oC, 45 oC, 50 oC, 55 oC, and 60 oC) as well after particles were 
exposed to NIR irradiation (Coherent Diode, 808 nm, 4 W/cm2, 2 min). Temperatures 
were maintained for at least 15 min before a reading was taken. Z-average hydrodynamic 
diameters of all groups were compared using an ANOVA with Tukey’s HSD (*p<0.05).    
5.3. Results 
5.3.1. Particle Characterization 
The extinction spectra of bare nanoshells, initiator-functionalized nanoshells, and 
NCNS are shown in Figure 5.8. Bare nanoshells were found to have a peak extinction at 
785 nm. This spectrum did not change significantly for the initiator-functionalized and 
NIPAAm-coated nanoshells; only a slight peak broadening towards the red was observed. 
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Figure 5.8. Extinction spectra of bare, initiator functionalized, and NIPAAm coated 
nanoshells. 
Bare, initiator-functionalized, and NIPAAm-coated nanoshells were analyzed 
using both DLS and zeta potential measurements (Figure 5.9). A slight increase in 
hydrodynamic diameter was seen between the bare and initiator-functionalized 
nanoshells (158.6 nm vs. 187.8 nm), with a much larger size seen with the NCNS (337.4 
nm). Similarly, an increase in surface charge was observed when functionalizing the 
nanoshells with the Br-initiator molecule (-48.5 mV for bare nanoshells vs. -27.0 mV for 
initiator-functionalized nanoshells).  
 105 
 
Figure 5.9. [A] DLS and [B] zeta potential measurements of bare, initiator 
functionalized, and NIPAAm coated nanoshells.  
Figure 5.10 shows TEM images of bare, initiator-functionalized, and NIPAAm-
coated nanoshells. Both the bare and initiator-functionalized nanoshells look very similar, 
as the initiator molecule is too small to be visible. However, the NCNS display a thin 
polymer coating around the electron dense gold nanoshell. These images were taken 
under vacuum, and therefore the hydrogel layer was fully dehydrated, leading the 
hydrogel coating appearing much thinner than it did under DLS analysis.  
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Figure 5.10. Representative TEM images of [A-B] bare, [C-D] initiator 
functionalized, and [E-F] NIPAAm coated nanoshells. Scale bars = 20 nm. 
 107 
5.3.2. Multiphoton Imaging  
In order to observe the NCNS in their hydrated state, multiphoton microscopy 
was employed (Figure 5.11). NCNS loaded with FITC-dextran [Figure 5.11A-D] 
displayed colocalized signals from both 2-photon induced luminescence of the gold-silica 
nanoshells (red, D) and fluorescence from the FITC-dextran loaded coating (green, C). 
Non-loaded NCNS (Figure 5.11E,F) displayed the signal from the gold-silica nanoshells 
(red, H) but minimal green signal (G) as no FITC-dextran was present.  
 
Figure 5.11.  Multiphoton images of FITC-loaded NCNS [A-D] and non-loaded 
NCNS [E-H]. [A] Signal from the gold-silica nanoshells core (red) overlayed with signal 
from FITC-dextran (green) indicates colocalization of both sigals. [E] Non-loaded NCNS 
display gold-nanoshell signal (red) with minimal FITC signal (green). [B-D; F-H] Inset 
indicated by red box in [A,E] showing FITC-dextran signal [C,G], gold-nanoshell signal 
[D,H], and overaly of both signals [B,F]. Scale bars = 15 µm (A,E) and 5 µm (B-D, F-H).  
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5.3.3. Thermal Deswelling Analysis  
The Z-average size, intensity-weighted size, and polydispersity index (PDI) of all 
sample groups are displayed in Table 5.3. Particle sizes ranged from 326 nm at 25 oC to 
270-280 nm after incubation at 60 oC or exposure to NIR irradiation, indicating that these 
particles display the same thermal properties as was seen in the bulk hydrogel-nanoshell 
composites described in Chapter 2. Figure 5.12 illustrates particle size dependence on 
temperature.  
Table 5.3. Particle size dependence on temperature and NIR exposure. 
Group Z-Average 
(nm) 
Intensity-
weighted 
Average (nm) 
PDI n= 
25 oC 326.33 ± 16.51 333.96 ± 28.34 0.190 ± 0.030 8 
37 oC 312.84 ± 14.40 301.13 ± 15.68 0.205 ± 0.003 3 
45 oC 305.27 ± 11.20 294.53 ± 11.38 0.186 ± 0.002 3 
50 oC 297.06 ± 10.84 286.34 ± 11.60 0.184 ± 0.012 3 
45 oC 288.97 ± 10.49 279.27 ± 18.51 0.159  ± 0.034 3 
60 oC 280.32 ± 5.62 273.51 ± 8.06 0.172 ± 0.009 3 
Post 
Irradiation 
 
270.65 ± 16.21 
 
 
253.48 ± 14.30 
 
 
0.219 ± 0.029 
 
4 
Further, no significant size differences were seen between particles incubated at 
25 oC or 37 oC, indicating the particles will be in their swollen state under physiological 
conditions. Particles exposed to NIR irradiation have a smaller diameter (p<0.02) 
compared to particles at 25 oC or 37 oC, indicating these particles have undergone the 
phase transition, releasing water from the poly(NIPAAm-co-AAm) coating (Figure 5.13).    
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Figure 5.12. Z-Average particle hydrodynamic diameter vs. temperature.  
 
Figure 5.13. Z-average hydrodynamic diameters of particles at 25 oC, 37 oC, and 
after exposure to NIR irradiation. Particles at 25 oC and 37 oC are not significantly 
different in size, but are both significantly larger than particles exposed to NIR 
irradiation.  (*p<0.01, ANOVA). 
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As was discussed in Chapter 4, these DLS measurements are dependent on many 
factors, including particle geometry and material refractive index, and therefore may not 
truly represent the particle’s real “size”. Furthermore, only a modest decrease in 
hydrodynamic diameter (~60 nm) was observed in response to elevated temperatures or 
NIR irradiation. While the collapse of the hydrogel coating may be very extensive, these 
modest changes in overall particle size are due to the fact the majority of the particle’s 
volume is made up the incompressible nanoshell. 
5.4. Discussion and Conclusions 
In this chapter, the composite material developed in Chapter 2 of this dissertation 
was synthesized as a thin poly(NIPAAm-co-AAm) hydrogel coating onto individual 
gold-silica nanoshells using a controlled polymerization technique known as SI-ATRP. 
Analysis by DLS showed that particles increased in size from ~160 nm to over 300 nm 
with the addition of this coating.  Further analysis by TEM indicates that these particles 
consist of an electron dense gold nanoshell core surrounded by a thin polymer layer. 
Further, the hydrodynamic diameter of these particles decreases in response to elevated 
temperatures and NIR irradiation, as was seen in the bulk composite material. Further, the 
size of these particles (~330 nm) should allow for use as an injectable platform.  
Both the SI-ATRP method used in this chapter and the hydrogel-template method 
described in Chapter 4 are capable of synthesizing of injectable-sized hydrogel-nanoshell 
composite particles. A detailed comparison of these two methods can be found in Table 
5.2. While the hydrogel template method allows for fabrication of particles in a wide 
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variety of shapes and sizes, it is limited by its lack of control over the number of 
nanoshells per hydrogel particle and difficulties regarding batch-size scale-ups. 
Table 5.4. Comparison of composite particle synthesis methods. 
	   Hydrogel-nanoshell composite 
particles (HNCPs, Ch. 4) 
Poly(NIPAAm)-coated 
nanoshells (NCNS, Ch. 5) 
Synthesis Composite particles polymerized 
in microfabricated hydrogel 
template 
Hydrogel synthesized off 
nanoshell surface via 
immobilized initiator molecule 
Particle 
geometry 
Can synthesize particles of any 
geometry that can be 
microfabricated into a mold 
Limited to geometry of metal 
nanoparticle core (sphere) 
Nanoshell 
loading 
Nanoshell distribution within 
particle population not controlled 
Single nanoshell per composite 
particle 
Scale-up 
considerations 
Synthesis done on 2D surface—
difficult to scale up 
Synthesis done in solution—ease 
of scale up 
 
As the NCNS synthesized by SI-ATRP consist of a single nanoshell per hydrogel 
particle and are synthesized in solution, rather than a 2D surface, which facilitates scaling 
up the number of particles synthesized per reaction, these particles were further 
investigated for their drug loading and release capabilities.  Next, the ability to load these 
particles with a cancer therapeutic (doxorubicin), release of this drug upon NIR 
irradiation, and in vitro validation of this platform using a murine colon carcinoma model 
was assessed. The results of these investigations will be discussed in Chapter 6.  
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6. Hydrogel Coated Nanoshells: Drug Loading and 
Release, in vitro Validation 
Successful tumor-targeted drug delivery carriers must meet four basic 
requirements: (1) retain (the drug during circulation), (2) evade (the body’s defenses), (3) 
target (the tumor tissue/vasculature), and (4) release (the drug, specifically at the tumor 
site) (Needham, 1999). The NCNS developed in Chapter 5 were designed to retain drug 
in the poly(NIPAAm-co-AAm)-hydrogel coating, target tumor tissue through the EPR 
effect (as they are synthesized as sub-500 nm particles), and release the drug payload 
upon NIR exposure. Furthermore, it is hypothesized that the poly(NIPAAm-co-AAm)-
hydrogel coating will act to help stabilize the particles and evade clearance from the 
bloodstream similarly to the PEG brushes utilized on many nanoparticle platforms.  
In previous studies utilizing gold-silica nanoshells, the particle surface is 
passivized the addition of PEG brushes to the nanoparticle surface. This coating serves 
several purposes, including preventing the nanoparticles from aggregating in the presence 
of physiological salt concentrations. Additionally, when these particles are injected in 
vivo this coating serves to minimize plasma protein adsorption. Furthermore, it has been 
shown that PEG coatings not only limit adsorption of blood proteins, but this in turn also 
results in a decrease in particle phagocytosis by macrophages (Zahr et al., 2006). In vivo, 
this prevents early clearance via the RES system, allowing for longer circulation times 
and increased tumor accumulation of particles.   
This chapter further evaluates the ability of NCNS to act as a drug delivery 
carrier. First, the stability of the particles under physiological salt conditions as well as 
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material cytotoxicity was evaluated.  Next, the ability to load doxorubicin into the NCNS 
and trigger its release by NIR light exposure was analyzed. Finally, the ability for this 
platform to deliver doxorubicin and elicit a therapeutic effect to colon carcinoma cells in 
vitro was confirmed.  
6.1. Materials and Methods 
6.1.1. Material Stability  
The poly(NIPAAm-co-AAm) hydrogel coating on the NCNS was hypothesized to 
prevent particle aggregation under physiological salt concentrations similarly to the PEG 
coatings used in previous gold-silica nanoshell studies. Therefore, particle stability of 
bare nanoshells, PEG-coated nanoshells, and NCNS in 100 mM NaCl was assessed.  
6.1.1.1. Synthesis of PEG-coated nanoshells 	   Gold-silica nanoshells (synthesis described in Section 2.4.1) were functionalized 
with PEG molecules via gold-thiol interactions. Methoxy-PEG-SH (mPEG-SH, 5000 Da, 
Laysan Bio) was dissolved in H2O at a concentration of 10 µM. Next, 1 ml of this mPEG-
SH solution was added to 9 ml of nanoshells at O.D. of 1.5 (4 x 109 particles/ml) and 
vortexed for 30 s. The solutions were then rocked overnight at 4 oC, and the next day the 
particles were purified from unreacted PEG molecules by centrifugation (735 x g, 5 min). 
6.1.1.2. Analysis of Particle Stability 
The quality of surface passivation can be assessed by analysis of particle behavior 
in a salt solution. When suspended in salt, nanoparticles that are not properly stabilized 
will form multi-particle aggregates, which in turn results in lowered peak extinctions. 
Therefore, UV-Vis spectroscopy was used to analyze the stability of nanoparticles with 
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different surface coatings. Bare nanoshells, PEG-passivated nanoshells, and NCNS were 
each suspended in 100 mM NaCl, and a UV-Vis spectrometer (Cary 50 Bio, Varian) was 
used to record the particle spectra every 60 min over 4 h. Stability was calculated for 
each time point by expressing the peak extinction at that time point as a percent of the 
peak extinction of that sample at the start of the test.  
6.1.2. Material Cytotoxicity   
In order to predict if any adverse reactions would occur in vivo upon exposure to 
the NCNS developed in Chapter 5, particle cytotoxicity was analyzed using the MTS 
assay, an established method for determining nanoparticle toxicity (Lewinski et al., 
2008). This colormetric assay measures metabolic activity, as tetrazolium salt is cleaved 
in the mitrochondria of living cells to produce a dark-blue formazan product, and can 
therefore be used to estimate the degree of cell viability in a sample. Cytotoxicity was 
analyzed against two different cell lines: mouse embroyonic fibroblasts (NIH 3T3s), a 
generic cell line commonly used in many cytotoxicity assays, and human 
hepatocarcinoma cells (HepG2s), as these cells have similar responses to hepatocytes and 
liver uptake of these particles is expected. Furthermore, both these cell types are common 
cell lines used for establishing nanoparticle toxicity (Lewinski et al., 2008). Both cell 
types were cultured in Dulbecco’s Modified Eagle Medium (DMEM) with 10% FBS, 100 
U/l penicillin, and 100 mg/ml streptomycin. Cultures were maintained at 37 oC and 5% 
CO2. 
Cells were seeded at 4500 cells/well (3T3s) or 9000 cells/well (HepG2s) in 96-
well plates. A lower concentration of 3T3 cells were seeded, as these fibroblasts are much 
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larger in size than the HepG2 cells. The next day, cells were exposed to particle 
concentrations of 0, 3750, 7500, or 15000 NCNS/cell with media/particle volumes of 120 
µl/well, with each condition tested in triplicate. After 48 hr, 26 µl of MTS reagent 
(Promega) was added to each well and the cells were incubated for 45 min at 37 oC and 
5% CO2. Media samples were then centrifuged (735 x g, 5 min) in order to pellet any 
nanoparticles in the suspension. Absorbance readings of the supernatant were measured 
at 490 nm.  Cell viability was then determined by measuring the average OD490 value for 
each treatment group and expressing the values as a percent of the average OD490 for the 
cell-only controls.  
6.1.3. Therapeutic Loading and Release  
Next, the ability to load and release doxorubicin from the NCNS was assessed. 
For loading, the NCNS were first pelleted by centrifugation (735 x g, 15 min) and 
resuspended in a 2 mg/ml solution of doxorubicin in TBS. This suspension was then 
rocked at 4 oC for 72 hr to allow for sufficient loading of the doxorubicin into the 
particles. After 72 hr, the doxorubicin-loaded NCNS were purified by 3 rounds of 
centrifugation (735 x g, 15 min). The amount of doxorubicin loaded into the particles was 
determined using UV-Vis spectroscopy. The doxorubicin-loaded particles displayed two 
distinct spectral peaks: a peak at 785 nm (the peak extinction of the NCNS) was used to 
determine the particle concentration, and a second peak at 485 nm was used to determine 
doxorubicin concentration.  
For release studies, doxorubicin-loaded NCNS were suspended in TBS at an OD 
of 0.5 (1.2 x 109 particles/ml). 500 µl aliquots of this suspension were either (1) exposed 
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to an NIR laser (Coherent, 808 nm, 4 W/cm2) for 3 min, (2) left at room temperature for 3 
min, or (3) left at room temperature for 72 hr, with each condition tested in triplicate. 
After exposure, the suspension was filtered through a 0.22 µm polyethersulfone 
membrane (Genesse Scientific) to separate the doxorubicin-loaded NCNS from the free 
doxorubicin in the sample. Doxorubicin content of the samples was then determined by 
measuring absorbance at 485 nm. The amounts of doxorubicin delivered under the three 
conditions were analyzed by an ANOVA with Tukey’s HSD. 
6.1.4. In vitro Validation 
Murine colon carcinoma cells (CT-26.WT cells, ATCC) were cultured in RPMI 
1640 media supplemented with 2 mM L-glutamine, 10 mM HEPES, 1 mM sodium 
pyruvate, 4.5 g/l glucose, 1.5 g/l sodium bicarbonate, 100 U/l penicillin, 100 mg/ml 
streptomycin, and 10% FBS. Cultures were maintained at 37 oC with 5% CO2. Cells were 
seeded at a density of 4000 cells/well in either fibronectin-coated 96-well plates (for cell 
proliferation assay and fluorescence imaging) or fibronectin-coated 8-well chamber slides 
(for darkfield imaging). Cells were allowed to adhere overnight before particle dosing, 
and each experimental group was assessed in triplicate.  
6.1.4.1. Particle Dosing and NIR Exposure 
Cells were exposed to six different experimental conditions: (1) NCNS loaded 
with doxorubicin, exposed to NIR irradiation, (2) NCNS loaded with doxorubicin (no 
irradiation), (3) NCNS, exposed to NIR irradiation, (4) 29 µg/ml free doxorubicin (~50 
nM, equivalent to the amount of doxorubicin loaded in the particles in group 1), or (5) no 
treatment. Cells were exposed to particles at an OD of 0.25 (~15,000 particles/cell). For 
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darkfield imaging studies, cells were exposed to NCNS at an OD of 0.25 and either 
irradiated or not irradiated. For all cases exposed to NIR irradiation, cells were irradiated 
at 808 nm at 4 W/cm2 for 3 min.  
6.1.4.2. Analysis Using Fluorescence and Darkfield Microscopy 
At 24 hr post particle dosing, cellular uptake of doxorubicin was assayed by 
fluorescent microscopy (560 nm excitation, 645 nm emission) using an Axiovert 135 
inverted fluorescent microscope (Zeiss). Additionally, cells were stained with DAPI to 
visualize cell nuclei. Doxorubicin fluorescence intensity was quantified using ImageJ 
(NIH) and analyzed using an ANOVA with Tukey’s HSD. 
For darkfield imaging, cells were fixed at 1 hr post particle dosing (30 min post 
irradiation). Chamber wells were removed then cover slipped and imaged with an 
Axiovert 135 inverted fluorescence microscope (Zeiss) configured with a CytoViva 
darkfield condenser and EXFO X-Cite 120 Illumination System.  
6.1.4.3. Analysis of Cell Viability 
At 24 hr post particle dosing, cell viability was assessed using an MTS assay. 
Media in each well was removed and fresh media with MTS reagent (Promega) was 
added (100 µl media/ 20 µl reagent per well). After a 60 min incubation at 37 oC and 5% 
CO2, absorbance readings of the media were taken at 490 nm. Absorbance readings were 
normalized to readings of the cell-only control (Group 5). Absorbance readings of the 
groups were compared using an ANOVA with a Tukey’s post-hoc test.  
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6.2. Results 
6.2.1. Material Stability  
The stability of bare nanoshells, PEGylated nanoshells, and NCNS under 100 mM 
NaCl was analyzed over 4 hr, with representative extinction spectra of the three particles 
types displayed in Figure 6.1.  
 
Figure 6.1. Extinction spectra of [A] NCNS, [B] PEGylated nanoshells, and [C] bare 
nanoshells after suspension in 100 mM NaCl for 0 hr (blue), 1 hr (red), 2 hr (green), 
3 hr (purple) and 4 hr (turquoise).  
For both the PEGylated and NCNS, the particle spectra did not change 
significantly over time, with peak absorption values maintaining over 95% of their 
original value over the 4 hr time period. The bare nanoshells, however, quickly 
aggregated and began to fall out of solution, as demonstrated by the rapid loss in peak 
absorption (Figure 6.2). These results suggest that the poly(NIPAAm-co-AAm) hydrogel 
coating of these particles is just as effective in preventing aggregation of particle under 
physiologically relevant salt concentrations as the PEG coatings commonly utilized on 
nanoshells. 
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Figure 6.2. Changes in peak extinction of NCNS (blue), PEGylated nanoshells (red), 
and bare nanoshells (green) over a 4 hr suspension in 100 mM NaCl. Both PEGylated 
and poly(NIPAAm-co-AAm)-coated nanoshells remained stable over the 4 hr period as 
determined by minimal changes in their extinction spectra, while bare nanoshells 
aggregated and precipitated over time. 
6.2.2. Material Cytotoxicity 
Both 3T3s and HepG2s were exposed to a range of NCNS concentrations for 48 
hr to determine if the poly(NIPAAm-co-AAm) coating induces any cytotoxic effects. 
Figure 6.3 displays cell viability at 48 hr in terms of percent viability as compared to 
untreated controls. Cell viability was greater than 90% in all groups, and no statistical 
differences were seen among any groups (ANOVA with Tukey’s HSD), indicating that 
NCNS do not exhibit any material cytotoxicity.  
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Figure 6.3.  Material Cytotoxicity. Viability of 3T3 fibroblasts (blue) and HepG2s (red) 
exposed to increasing NCNS concentrations. Cell viability remained >90% in all groups 
and no statistical significance was observed among any groups by ANOVA. 
6.2.3. Therapeutic Loading into Particles 
Doxorubicin loading into the NCNS was assessed using UV-Vis spectroscopy. 
Spectra of NCNS at a concentration of 1.2 x 109 particles/ml and NCNS loaded with 
doxorubicin are shown in Figure 6.4A. The spectrum of the NCNS loaded contains two 
distinct peaks: one at 785 nm (as seen in unloaded NCNS) and one at 485 nm, as seen in 
the spectrum of doxorubicin. Furthermore, these two peaks can be separated by 
subtracting the NCNS spectrum from the NCNS + doxorubicin spectrum, yielding a 
spectrum with one peak which closely matches the spectrum of doxorubicin in solution 
(Figure 6.4B). From the two peaks in the NCNS + doxorubicin spectrum, both the 
number of particles [estimated using a Mie theory simulation (Averitt et al., 1999a) based 
on the peak at 785 nm] and the amount of doxorubicin loaded into the particles 
(estimated from the peak at 485 nm and using the concentration curve in Figure 6.4C) can 
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be calculated. Overall, doxorubicin loading was calculated to be 48.4 ± 0.3 µg of 
doxorubicin/109 particles, or approximately 5 x 107 doxorubicin molecules per particle.  
 
Figure 6.4.  Loading of doxorubicin into NCNS. [A] Spectrum of NCNS + doxorubicin 
(blue) and NCNS at an OD of 0.5 (1.4 x 109 particles/ml, red). [B] The result of 
subtracting the NCNS spectrum from the NCNS + doxorubicin spectrum (green) closely 
matches the spectrum of doxorubicin at 0.07 mg/ml (purple). [C] Standard curve relating 
absorbance at 485 nm to concentration of doxorubicin in solution.  
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6.2.4. Therapeutic Release from Particles 
Doxorubicin release from particles exposed to NIR irradiation or left at room 
temperature is displayed in Figure 6.5. Particles exposed to NIR irradiation released 22.2 
± 1.4 µg doxorubicin/109 particles, or approximately 46% of their payload. Minimal 
release was seen from particles that were not irradiated over the 3 min period. 
Additionally, only 6.6 ± 0.5 µg doxorubicin/109 particles, or less than 15% of the 
payload, was released from the particles after 72 hr at room temperature. Overall, these 
results indicate that 3 min of NIR irradiation is sufficient to trigger the delivery of a 
significant amount of doxorubicin from this delivery platform.  
 
Figure 6.5. Delivery of doxorubicin from NCNS. After only 3 min of NIR irradiation, 
approximately 46% of the loaded doxorubicin is released from the particles. Release due 
to diffusion at room temperature is minimal, with less than 15% of the payload released 
over 72 hr.   
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6.2.5. In vitro Validation 
6.2.5.1. Darkfield Microscopy 
Due to the scattering properties of gold-silica nanoshells, these particles have 
been previously utilized as contrast agents for darkfield microscopy, a technique in which 
light strikes a sample at an angle so that only scattered light is captured (Loo et al., 2005). 
Since the poly(NIPAAm-co-AAm) hydrogel coating is fairly optically clear, it is 
hypothesized that the NCNS should retain similar scattering properties as seen in gold-
silica nanoshells. Cells were exposed to NCNS for 60 min followed by fixation and 
darkfield imaging. Figure 6.6 clearly shows that NCNS can be visualized under darkfield 
microscopy. Non-irradiated NCNS (Figure 6.6A) appear as single particles dispersed 
throughout the entire sample, while irradiated NCNS (Figure 6.6B) tend to form more 
particle aggregates.  
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Figure 6.6. Darkfield microscopy images of NCNS distributed among CT.26WT 
cells. [A] Nonirradiated NCNS show a uniform distribution across the entire sample, 
whereas [B] irradiated NCNS tend to form multi-particle aggregates. Scale bars = 100 
µm.  
6.2.5.2. Doxorubicin Uptake 
Fluorescence microscopy was used to analyze the amount of doxorubicin uptake 
by cells exposed to irradiated NCNS-doxorubicin particles, nonirraditaed NCNS-
doxorubicin particles, and free doxorubicin at 24 hr post particle dosing. Figure 6.7 
shows that cells exposed to irradiated NCNS-doxorubicin particles displayed nearly 3 
times as much doxorubicin fluorescence per cell compared to the other two groups, 
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indicating that doxorubicin released from these irradiated particles efficiently enters the 
cells.  
 
Figure 6.7. Uptake of doxorubicin by CT.26WT cells. [A-C] Phase contrast images 
overlayed with doxorubicin fluorescent signal for cells exposed to [A] irradiated NCNS-
doxorubicin particles, [B] non-irradiated NCNS-doxorubicin particles, and [C] free 
doxorubicin. Scale bars = 100 mm [D] Quantification of doxorubicin fluorescence 
intensity per cell. Cells exposed to irradiated NCNS-doxorubicin particles showed almost 
3x more doxorubicin fluorescence than the other groups (*p<0.0001, ANOVA). 
Further analysis showed that the doxorubicin delivered by irradiated NCNS-
doxorubicin particles is highly nuclear localized, as indicated by colocalization of both 
doxorubicin and DAPI fluorescence signals (Figure 6.8). Doxorubicin’s main mechanism 
of action involves inhibition of topoisomerase-II, eventually causing permanent DNA 
damage and inhibition of cell proliferation (Tewey et al., 1984). This nuclear localization 
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of doxorubicin fluorescence suggests the drug is effectively entering the cells and 
available for inducing DNA damage. 
 
Figure 6.8. Cellular distribution of doxorubicin delivered from irradiated NCNS-
doxorubicin particles. [A] Doxorubicin fluorescence signal localizes closely with [B] 
DAPI signal from cell nuclei, as demonstrated by an overaly of these two signals [C]. 
Scale bars = 50 µm. 
6.2.5.3. Analysis of Cell Viability 
To demonstrate that NCNS-doxorubicin particles can effectively deliver their 
therapeutic payload to CT.26WT cells upon NIR irradiation, cell viability was assessed 
24 hr after particle dosing for the five conditions described in Section 6.1.4.1. Figure 6.9 
displays these results. Cells exposed to NCNS-doxorubicin particles exposed to NIR 
irradiation resulted in almost a 90% decrease in cell viability compared to non-treated 
controls, whereas when these particles were not irradiated, but allowed to release 
doxorubicin via slow passive diffusion, only a 55% decrease was seen. Additionally, cells 
exposed to non-drug loaded NCNS that were irradiated did not show any changes in 
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viability, indicating the heating generated by these particles alone at this laser intensity 
and irradiation time was not sufficient to cause cell death. 
 
Figure 6.9. Changes in cell viability due to various treatment groups. Cells exposed 
to NCNS-doxorubicin particles triggered to release their doxorubicin payload by NIR 
irradiation showed increase loss is cell viability compared to cells exposed to NCNS-
doxorubicin particles not exposed to NIR irradiation or free doxorubicin. Additionally, 
the heating caused by irradiating the NCNS alone was not sufficient to cause any cell 
death. Groups not connected by the same letter are statistically different from each other 
(ANOVA with Tukey’s post-hoc). 
6.3. Discussion and Future Directions 
The studies presented in this chapter aimed to (1) validate that the NCNS 
developed in Chapter 5 are stable under physiological salt conditions and do not exhibit 
any material cytotoxicity, (2) analyze the loading capacity of these particles with the 
chemotherapeutic doxorubicin and trigger release of the drug in response to NIR 
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irradiation, and (3) investigate the ability of these doxorubicin-loaded NCNS to deliver 
their payload and elicit a therapeutic response in vitro.  
The poly(NIPAAm-co-AAm) coating passivates the particle surface, preventing 
aggregation under salt conditions as effectively as the PEG coating traditionally used on 
gold nanoparticle platforms. Furthermore, these particles did not elicit any cytotoxicity 
against either fibroblasts or hepatic cells in vitro. The chemotherapeutic doxorubicin was 
loaded into the particles to a concentration of 5 x 107 drug molecules/particle, and 46% of 
the payload was released after just 3 min of NIR irradiation, whereas less than 15% was 
nonspecifically released over 72 hr. Furthermore, using darkfield microscopy it was seen 
that non-irradiated particles appear to be uniformly distributed throughout the sample, 
whereas irradiated particles tend to form larger particle aggregates. This is likely due to 
the hydrogel coating becoming more hydrophobic following its phase transition into a 
collapsed state, providing a driving force for aggregation in aqueous solutions.  
Further analysis showed that this platform can effectively deliver its doxorubicin 
payload to colon carcinoma cells in vitro. Cells exposed to irradiated particles displayed 
nearly 3 times as much doxorubicin uptake as cells exposed to non-irradiated particles or 
free drug, as assessed by fluorescence microscopy. This in turn also resulted in a higher 
loss in cell viability. These differences may be due to the effects of the particle heating. 
Previous studies utilizing gold nanoshells have shown that nanoshell irradiation causes 
transient increases in membrane permeability (Hirsch et al., 2003, Day et al., 2010). As 
irradiation of this platform causing a release of high concentrations of drug molecules 
and induces an increase in membrane permeability at the same time, there is an increased 
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ability for drug molecules to enter the cell, causing increased uptake compared to non-
irradiated particles or free drug controls.  
Current and future efforts are focusing on investigating the in vivo efficacy of 
these doxorubicin-loaded NCNS. Such studies will be accomplished using mice with 
subcutaneous tumors. The maximum tolerated dose of doxorubicin in mice is ~5 mg/kg 
(MacKay et al., 2009), and the average weight of a mouse is ~30 g, translating to a 
maximum dose of 150 µg doxorubicin/mouse. Based on the loading of ~48 µg 
doxorubicin/109 particles achieved in this work, ~3.12 x 109 particles would be needed to 
achieve the maximum tolerated dose of free doxorubicin in mice. These particle 
concentrations are well below gold-silica nanoshell doses that have been previously used 
in mice (~1011 particles/mouse) (O'Neal et al., 2004), indicating relevant amounts of 
doxorubicin can be loaded into this platform.  Further discussion of these investigations 
can be found in Section 8.3.1. 
6.4. Conclusions  
The work presented in Chapter 5 and 6 shows that the thermally-responsive 
composite material developed in Chapter 2 can be synthesized as injectable-sized 
particles. These particles retain the same properties as the bulk material: decreasing in 
size in response to both elevated temperatures or NIR irradiation. These particles can be 
loaded with doxorubicin and triggered to release their payload, and delivery from this 
platform results in an increased drug uptake compared to free drug, likely due to platform 
irradiation causing a transient increase in cell membrane permeability. In fact, under the 
laser conditions used, heating alone did not result in any cell death but appeared to 
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increase delivery of the drug payload. This transient increase in membrane permeability 
could be especially advantageous for drug molecules that cannot normally diffuse across 
a cell membrane, such as nucleic acid therapeutics. Chapter 7 of this dissertation further 
explores this irradiation-mediated membrane permeability for delivery of siRNA. 
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7.  NIR Irradiation Mediated Uptake of siRNA 
As was discussed in Section 1.2.1, nucleic acid-based therapeutics such as siRNA 
are large, anionic, and hydrophilic, and therefore cannot readily cross cell membranes via 
passive diffusion (Oh and Park, 2009). In order to improve delivery of such material, 
several viral-based delivery vehicles (commonly based on retroviruses and adenoviruses), 
as well as non-viral delivery vehicles (comprised of lipids, polymers, dendrimers, 
polypeptides, and nanoparticles), have been developed (Mintzer and Simanek, 2008). In 
addition, physical methods have been developed to compromise cell membrane integrity 
in order to increase delivery of genetic material, with a number of such approaches 
discussed in Table 7.1. However, most of these methods have severe drawbacks in vivo, 
including scale-up (seen with microinjection, where individual cells must be 
manipulated), tissue targeting and penetration (seen with the “gene gun” approach and 
sonoporation), and invasiveness (seen with electroporation).  
Table 7.1. Summary of physical techniques used to increase cellular uptake of 
genetic material (Mehier-Humbert and Guy, 2005). 
Physical Technique Principle Materials 
Required 
Limitations in vivo 
Microinjection Manual injection into 
individual cells 
Micropipette, 
microscope 
Scale up—each cell 
must me manually 
manipulated 
Gene Gun High-velocity particle 
bombardment 
“Gene gun”, gold 
particles 
Poor penetration 
across tissues 
Electroporation Electric field-induced 
cell membrane 
permeabilization 
Electrodes, pulse 
generator 
Toxicity, 
invasiveness 
(electrodes) 
Sonoporation Ultrasound-induced 
cell membrane 
permeabilization 
Ultrasound probe, 
gas microbubbles 
Efficacy, targeting 
only to disease sites 
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As has been previously discussed, the photothermal effects of gold-silica nanoshells 
are tightly localized to where NIR laser application and particles are combined. In 
addition, NIR permissibility across tissues allows for much deeper penetration depths 
than can be obtained by the “gene gun” approach. Therefore, the ability for irradiated 
gold-silica nanoshells to induce membrane permeability and augment cellular uptake of a 
nucleic acid therapy (siRNA) was investigated. 
7.1. Effects of Gold-Nanoshell Irradiation on Cell Membranes 
Previous studies of photothermal ablation using NIR absorbing nanoparticles 
suggest that heating due to the nanoparticle irradiation causes a loss in cell membrane 
integrity, leading to cell death. This phenomena was first reported in a study by Hirsch et 
al., in which SK-BR-3 carcinoma cells showed uptake of a fluorescent dextran molecule 
(MW 10,000) after incubation with gold-silica nanoshells and NIR irradiation for 7 min 
at 35 W/cm2 (Figure 7.1) due to compromised cell membrane barriers (Hirsch et al., 
2003).  
 
Figure 7.1. NIR irradiation increases cell membrane permeability. Cells irradiated in 
the presence of nanoshells (right) showed an increase in membrane permeability, as 
indicated by uptake of FITC-labeled dextran (10,000 MW). Cells exposed to NIR 
irradiation without nanoshells displayed minimal FITC-dextran uptake (left). Adapted 
from (Hirsch et al., 2003). 
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These changes in cell membrane integrity were further observed using NIR 
absorbing gold-gold sulfide nanoparticles exposed to a pulsed 810 nm laser (Day et al., 
2010).  Figure 7.2 shows time-lapse images of SK-BR-3 cells incubated with gold-gold 
sulfide nanoparticles exposed to NIR irradiation over 30 sec. Within 10 sec of exposure, 
membrane blebbling begins to occur, and further membrane damage as indicated by 
diffusion of a DiI membrane dye is seen after 30 sec (Day et al., 2010).  
 
Figure 7.2. Cells incubated with gold-gold sulfide nanoparticles and exposed to a 50 
mW femtosecond pulsed Ti:sapphire laser over 30 sec. A DiI membrane stain (red) 
shows membrane blebbing (indicated by arrows) occurring within 10 sec of laser 
exposure, with extensive membrane damage seen at 30 sec. Scale bars = 20 µm. Adapted 
from (Day et al., 2010). 
Work in this chapter investigates whether this NIR irradiation induced cell 
membrane permeability can be exploited for the delivery of large, charged molecules, 
such as siRNA, which cannot diffuse through non-compromised cell membranes easily.   
7.2. Materials and Methods 
All reagents were purchased from Sigma-Aldrich and used as received, unless 
otherwise noted. All water used in synthesis, purification, and testing was treated by a 
Milli-Q system (≥18.0 MΩ.cm resistivity). 
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7.2.1. Cell Culture 
Human prostate cancer cells (PC-3s) were cultured in Ham’s F-12K media 
supplemented with 10% FBS, 100 U/l penicillin, and 100 mg/ml streptomycin. Cultures 
were maintained at 37 oC and 5% CO2. For all studies cells were seeded at a density of 
30,000 cells/well in 96-well plates.  
7.2.2. Effects of Laser Power on Cell Viability 
PC-3 cells were seeded at a density of 30,000 cells/well in 96-well plates and 
allowed to adhere overnight. The next day, gold-silica nanoshells at an O.D. of 4.5 (~1.3 
x 109 particles/well) were added to the cell media and incubated for 30 min. Next, cells 
were irradiated with an 808 nm laser for 1 min at power densities of 2, 4, 6, 8, 10, or 20 
W/cm2. Cells were incubated for an additional 30 min, and viability staining was then 
assessed using calcein AM and ethidium homodimer-1 following the manufacturer’s 
instructions (Life Technologies) and visualized using an Axiovert 135 inverted 
fluorescence microscope (Zeiss). Calcein AM is membrane permeable and cleaved by 
esterases found in live cells to produce a fluorescent green calcein product. Ethidium 
homodimer-1 cannot cross the membranes of live cells, but easily passes into dead cells 
with compromised membranes, binds to nucleic acids and fluoresces red.  
7.2.3. Cellular Uptake of siRNA 
Based on the laser power studies described, in Section 7.2.2, a laser power of 4 
W/cm2 and irradiation time of 1 min was chosen for transfection studies, as it was slightly 
below where cell death began to occur, and hypothesized that this power may cause 
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transient membrane permeability without causing cell death. Next, the ability for an 
siRNA molecule to be uptaken by cells under these conditions was assessed.  
PC-3s were seeded at 30,000 cells/well in 96-well plates and allowed to adhere 
overnight. The next day, media containing nanoshells at an O.D. of 4.5 (~1.3 x 109 
particles/well), 100 mM AF-488 tagged siRNA (Qiagen) was added to the cells and 
incubated for 30 min. Cells were then irradiated at 4 W/cm2 for 1 min, and then incubated 
for an additional 30 min. After 30 min, the cells were rinsed 3 times with PBS, fixed 
using gluteraldehyde, stained with DAPI, and visualized with an Axiovert 135 inverted 
fluorescence microscope (Zeiss). Additionally, control groups where cells were exposed 
to both gold nanoshells and siRNA (without being irradiated by the NIR laser) or exposed 
to siRNA and irradiated (without nanoshells) were also analyzed. SiRNA uptake was 
quantified using the fluorescence intensity measurements using ImageJ (NIH) and 
compared using an ANOVA with Tukey’s HSD.  
7.3. Results 
7.3.1. Effects of Laser Power on Cell Viability 
The effects of laser power on cell viability were investigated by exposing cells 
incubated with nanoshells to increasing laser powers for 1 min, followed by analysis of 
cell viability using a live/dead assay.  Results, shown in Figure 7.3, indicate that cells 
exposed to laser powers up to 4 W/cm2 remained viable. Small numbers of dead cells 
were observed with a 6 W/cm2 exposure, and increasing amounts of cell death were seen 
as laser powers were further increased. Based on these results, a laser power of 4 W/cm2 
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was chosen for siRNA uptake studies, with the hypothesis it would elicit increased 
membrane permeability without causing cell death.   
 
Figure 7.3. Effects of laser power on cell viability. Calcein AM (green, live) and 
ethidium homodimer-1 (red, dead) signal from cells exposed to 808 nm light at [A] 2, [B] 
4, [C] 6, [D] 8, [E] 10, or [F] 20 W/cm2 for 1 min. Increased cell death was observed with 
increased laser powers. Scale bars = 200 µm. 
7.3.2. Cellular Uptake of siRNA 
Cellular uptake of siRNA was analyzed by fluorescence microscopy 30 min after 
NIR laser exposure (Figure 7.4). Cells exposed to both nanoshells and NIR irradiation 
displayed fluorescence signal from the AF-488 tagged siRNA molecule, while minimal 
signal of this siRNA was seen in controls exposed to either nanoshells or NIR irradiation 
alone.  
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Figure 7.4. NIR irradiated nanoshells increase cellular uptake of siRNA. Cells 
exposed to both nanoshells and irradiation [A-C] showed increased signal of AF488-
siRNA compared to nonirradiated cells exposed to nanoshells [D-F] and irradiated cells 
without nanoshells [G-I]. Images [A], [D], and [G] show signal from the AF488-siRNA, 
images [B], [E], and [H] show nuclear staining by DAPI, and images [C], [F], and [H] 
show and overlay of the two signals. Scale bars = 200 µm.  
Uptake of siRNA was quantified by analyzing differences in AF-488 siRNA 
fluorescence intensity for the three groups. Cells exposed to both nanoshells and NIR 
irradiation showed over 25 times more siRNA uptake than the controls (Figure 7.5) 
indicating that this NIR irradiation induced membrane permeability causes increased 
delivery of siRNA molecules into cells.  
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Figure 7.5. Quatification of AF488-siRNA fluorescence intensity. Cells exposed to 
NIR irradiated gold nanoshells displayed more than 25 times higher signal from the 
AF488-siRNA than nanoshell only and irradiation only controls. *p<0.001, ANOVA.  
7.4. Conclusions and Future Directions  
In this chapter, particle concentration and NIR laser settings were optimized in 
order to compromise cell membrane integrity without causing cell death due to heating. 
These setting elicited an increase in membrane permeability, which could be effectively 
exploited to delivery siRNA molecules which cannot easily diffuse through non-
compromised cell membranes 
Further studies should be performed to confirm the delivered siRNA molecules 
are functional and capable of knocking down protein expression of a target of interest. 
Additionally, while this study looked at co-delivery of nanoshells and free siRNA in cell 
media, further optimization should be done to load the siRNA into the NCNS developed 
 139 
in Chapter 5 in order to create a single platform with both the therapeutic molecule 
(siRNA) and the membrane permeablizing agent (gold nanoshell).  
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8. Concluding Remarks and Future Directions 
8.1. Introduction  
Composite materials comprised of thermally responsive polymers and optically 
absorbing nanoparticles couple the ability of the nanoparticles to convert an external 
stimuli to heat with polymers that display sharp property changes in response to 
temperature changes, thus allowing for external control over polymer properties. Such 
systems have a variety of biomedical applications, including drug delivery. The goal of 
this dissertation was to develop an injectable-sized platform consisting of a thermally-
responsive poly(NIPAAm-co-AAm)-gold nanoshell composite capable of externally-
controlled, site-specific cancer therapy. Herein, the significance of the results of this 
dissertation will be presented and potential future studies and impact of this platform are 
discussed.  
8.2. Summary of Work Presented and Significance  
The platform in this dissertation was developed with two main goals in mind: (1) 
to encapsulate a therapeutic cargo as the platform circulated throughout the body, and (2) 
to trigger release of this cargo at a specific time and location. The first goal was 
accomplished by the utilization of a thermally-responsive poly(NIPAAm-co-AAm) 
hydrogel. This material acts similarly to a sponge, allowing therapeutic molecules to be 
absorbed within its pores. In addition, this hydrogel was found to have an LCST of 39-45 
°C, thereby existing in a swollen state at physiologic temperature. The second goal was 
accomplished by the encapsulation of gold-silica nanoshells into the hydrogel. The 
nanoshells used in this thesis were tuned to have a peak absorption in the near-infrared 
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range, where biological tissue is most permissive to light. When exposed to light in this 
range, the nanoshells heated and elicited a temperature increase of surrounding material. 
This caused the hydrogel material to collapse and rapidly expel large amounts of water, 
demonstrating the capability of optically triggering this material phase transition. 
Initial validation of this composite material was carried out using poly(NIPAAm-
co-AAm) hydrogel discs (~4 mm in diameter) with encapsulated gold-silica nanoshells. 
This material could be loaded with a variety of therapeutic molecules ranging from small 
molecule chemotherapeutics (doxorubicin, ~580 Da) to large nucleic acid therapeutics 
(siRNA model molecule, ~14 kDa). NIR light exposure could effectively trigger release 
of both these molecules from the hydrogel material. Furthermore, doxorubicin delivered 
from this material could effectively enter cancer cells and elicit a therapeutic response. 
Overall, the work presented in Chapters 2-3 validated the potential for this composite 
material to be used for controlled delivery of cancer therapeutics.   
Towards the translation of this composite material into in vivo applications, the 
composites were synthesized as injectable-sized particles rather than bulk discs. Chapters 
4 and 5 investigated two different methods for the synthesis of such particles. In Chapter 
4, a molding technique using a dissolvable gelatin template was used. In Chapter 5, 
surface initiated-atom transfer radical polymerization was employed to grow a layer of 
poly(NIPAAm-co-AAm) hydrogel onto individual nanoshells. Both methods successfully 
synthesized particles consisting of a nanoshell core surrounded by thin polymer layer, as 
analyzed by TEM. Furthermore, the hydrodynamic diameter of these particles decreased 
in response to either incubation at elevated temperatures or exposure to NIR irradiation, 
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proving that these particles retain the same thermal properties as the bulk material.    
The hydrogel template method used in Chapter 4 did not allow for direct control 
over how many nanoshells were contained in each hydrogel particle, thus resulting in a 
heterogeneous particle population. Also, as each mold had to be manipulated 
individually, batch-size scale-ups proved difficult. For these reasons, particles 
synthesized using SI-ATRP were further explored for use as a drug delivery carrier in 
Chapter 6.  
The hydrogel coating on the particles was found to act similarly to the PEG 
coatings commonly employed on metal nanoparticle platforms by effectively passivating 
particle surface and preventing aggregation under physiological salt concentrations. 
Additionally, the particles displayed no material cytotoxicity. Doxorubicin could be 
effectively loaded into the particles to concentration of ~5 x 107 doxorubicin 
molecules/particle, and NIR light exposure could trigger ~40% of the drug to release in 
just 3 min. Finally, the ability for this platform to deliver doxorubicin and elicit a 
therapeutic effect to colon carcinoma cells in vitro was confirmed. Notably, cells exposed 
irradiated doxorubicin-loaded particles should both increased doxorubicin uptake and 
loss of cell viability compared to free drug controls. It is hypothesized this is due to an 
increase in cell membrane permeability due to the particle heating, which in turn 
increases the ability of the drug to diffuse across the cell membrane compared to non-
irradiated or free drug controls.  
Finally, the ability for irradiated gold-silica nanoshells to induce membrane 
permeability and augment cellular uptake of a nucleic acid therapy (siRNA), which 
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normally does not diffuse across cell membranes easily, was further investigated in 
Chapter 7. 
This ability to precisely control therapeutic delivery to malignant tissue would 
undoubtedly improve cancer management by overcoming the limitations of current 
therapies. The controlled release system designed would decrease the off-site toxicities of 
systemic chemotherapeutic regimens by minimizing drug exposure to non-malignant 
tissues, as well as increase the serum stability of fragile biologic therapeutics. Ultimately, 
this platform can be used to attack tumor tissue using two distinct mechanisms 
simultaneously: (1) photothermal heating and (2) delivery of multiple type of therapeutic 
molecules, providing a novel approach to effectively treat cancers when standard 
treatment modalities are not adequate.  
8.3. Future Directions  
8.3.1. In vivo Validation  
Current and future efforts are focusing on investigating the in vivo efficacy of 
these doxorubicin-loaded NCNS. These studies are designed based on previous in vivo 
studies utilizing PEG-passivated gold nanoshells (see Section 2.1.3.2). In previous studies 
utilizing gold-silica nanoshells for photothermal therapy, the tumor is irradiated 
approximately 24 hours post nanoshell injection, as this is when nanoshell accumulation 
in tumor tissue is at a maximum (Gobin et al., 2007, Day et al., 2011). Because the 
hydrogel particles created in this study are of similar size to the PEGylated nanoshells 
used in these studies, a similar distribution is expected with tumor accumulation to be 
maximum 24 hours post injection, but a biodistribution study will be performed to 
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validate this hypothesis. If tumor accumulation is of these larger particles is limited, 
utilizing a smaller NIR absorbing particle type, such as gold-gold sulfide (Averitt et al., 
1997) or hollow gold nanospheres (Lu et al., 2009), both of which are typically ~40 nm 
may be necessary.  
After validation of particle accumulation in tumor tissue, a study comparing 
treatment using doxorubicin-loaded NCNS, non drug-loaded NCNS, and free 
doxorubicin will be performed. At 24 hours post-injection, mice will be exposed to an 
NIR laser (808 nm, 4 W cm2, 3 min) as these conditions have been previously utilized in 
in vivo studies using gold-silica nanoshells (Day et al., 2011). After treatment, tumor 
growth and animal survival will be analyzed. It is hypothesized that mice treated with 
doxorubicin-loaded NCNS will show increased survival over the other groups due to the 
additive and potentially synergist treatment involving both heat and drug delivery.  
8.3.2. Drug Combinations  
The developed platform has the inherent ability to deliver a range of molecules, 
from small chemical drugs to large biologic therapeutics. It is the norm for most patients 
is to receive a cocktail of many different drugs rather than a single agent since 
combinations of drugs with different mechanisms of action show benefit in preventing 
drug resistant tumor cells (Chabner and Roberts, 2005). It is conceivable that this 
material could be loaded with multiple chemical therapeutics for delivery to a patient. 
Additionally, much research has been done showing an increased benefit of combining 
siRNA therapy with a chemotherapeutic such as doxorubicin, especially for multi-drug 
resistant cancers (Saraswathy and Gong, 2014); Table 8.1 details previous studies of 
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codelivery of doxorubicin and siRNA. The versatility of this platform for use with 
multiple types of therapeutics would allow for an ease of implementation of such 
regimens, ultimately leading to an improvement in cancer management. 
Table 8.1. Studies of codelivery of doxorubicin and siRNA. 
siRNA Target Platform 
Material 
Cancer Type Admin-
istration 
Citation 
MDR-1 (drug 
resistance) 
Polymeric micelle 
(PEO-b-PCL) 
MDA-MB-435/ 
LCC6MDR1 
(MDR1 resistant 
breast carcinoma) 
Intravenous 
injection 
(mice) 
(Xiong and 
Lavasanifar, 
2011) 
MDR-1 (drug 
resistance) 
PEI coated 
mesoporous silica 
nanoparticles 
KB-V1 (MDR1 
resistant cervical 
carcinoma) 
in vitro (Meng et al., 
2010) 
MDR-1 (drug 
resistance) 
Phospholipid 
(DOPE)-PEI 
micelle 
MCF-7 (breast 
carcinoma) 
in vitro (Navarro et 
al., 2011) 
MDR-1 (drug 
resistance) 
CdSe/ZnSe 
quantum dots 
HeLa/Dox 
(doxorubicin 
resistant cervical 
cancer) 
in vitro (Li et al., 
2012) 
BCL-2 (anti-
apoptosis) 
Folate targeted 
polymeric micelle 
(PEI-b-PCL) 
Rat C6 Glioma Intratumora
l injection 
(rats) 
(Cheng et 
al., 2012) 
BCL-2 (anti-
apoptosis) 
Nanostructured 
lipid carrier 
A549 (lung 
carcinoma) 
Inhalation 
(mice) 
(Taratula et 
al., 2013) 
BCL-xL (anti-
apoptosis) 
Polymersome 
(mPEG-b-PLA) 
MKN-45, MKN-
28 (gastric cancer) 
in vitro (Kim et al., 
2013) 
Survivin (anti-
apoptosis) 
mPEG-PLA/EPL 
polymer 
nanoparticles 
B16-F10 
(melanoma) 
Intravenous 
(mice) 
(Wang et al., 
2013) 
Nuclear Factor 
ΚΒ p65 (anti-
apoptosis) 
Polyglutamate 
brushes 
HeLa (cervical 
cancer) 
in vitro (Zhao et al., 
2013) 
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8.3.3. Clinical Translation 
For translation of any optically-triggered platforms into a clinical setting, critical 
attention must be paid to laser-tissue interactions. NIR light was chosen as the optical 
trigger for this platform, as these wavelengths can penetrate soft tissue at a lower loss and 
lower risk of normal tissue damage compared to other wavelengths; NIR light can 
typically penetrate on the order of centimeters in soft tissue. This is because the main 
absorbers in soft tissue, water and proteins such as hemoglobin, do not significantly 
absorb light in this range. However, anatomical sites behind tissues such as bone or the 
chest wall may not be accessible to an external NIR light source. Additionally, intensity 
losses due to the scattering effects in tissue causes NIR light to become attenuated over 
long distances even in soft tissue, complicating treatment of deep-seeded tumors. In these 
cases, rather than exposing tumors to an external NIR source, use of a fiber optic probe 
that could be placed internally may be more appropriate. It is also important to note and 
adhere to the safety guidelines regarding maximum permissible exposures of lasers 
established by the Center for Devices and Radiological Health. In particular, there are 
limits regarding laser powers and exposure times acceptable for skin exposure in order to 
prevent skin burns and other adverse effects (Niemz, 2004). Additionally, there are 
several NIR fiber probes already approved for clinical use.  
From past in vivo photothermal ablation studies, it has been found that a ~15 oC 
increase in temperature is required to cause cancer necrosis. This temperature increase 
can be tuned by both the nanoshell concentration in the tumor as well as the laser power 
used (with higher concentrations and laser powers leading to greater temperature 
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increases). The laser powers and durations used in this work (808 nm, 4 W/cm2, 3 min) 
have been previously used for in vivo photothermal ablation studies and are below 
maximum permissible exposure values (O'Neal et al., 2004).  
There are several potential sites for clinical application of an optically-triggered 
delivery platform. In the case of brain malignancies such as glioblastoma, photothermal 
therapy using gold nanoshells have shown promise as a potential treatment (Day et al., 
2011, Day et al., 2012), and controlled drug delivery systems (Gliadel wafers) have 
shown much clinical success in this disease site (Westphal et al., 2003).  One could 
envision a treatment scheme where chemotherapeutic-loaded particles were administered 
pre-surgery, and following resection tumor margins could be irradiated to prevent 
likelihood of recurrence. Alternatively, recent studies suggest combining regional 
hyperthermia with chemotherapy is more efficacious than chemotherapy alone in treating 
soft tissue sarcoma (Issels et al., 2010). A platform that combines both localized heating 
and chemotherapeutic delivery could be advantageous for such treatments. Additionally, 
while the platform in this work is designed to passively target tumor tissue through the 
EPR effect, active targeting of nanoparticles to tumor tissues via the addition of targeting 
moieties on the nanoparticle surface is a widely researched area today (Byrne et al., 
2008). The hydrogel-coated nanoparticles developed could be functionalized with ligands 
such as antibodies, peptides, or aptamers, that selectively bind to antigens uniquely over-
expressed in tumor tissue. Such an approach may be beneficial for the treatment of 
HER2+ breast cancer, in which nanoparticle platforms functionalized with antiHER2 
antibodies have shown tremendous potential (Park et al., 2004, Lowery et al., 2006).  
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Ultimately, the platform developed in this work has the ability to overcome limitations of 
conventional cancer therapy, such as off-target effects, by tightly controlling therapeutic 
effects including heating and burst delivery of chemical or biological agents. In the 
future, such approaches have potential for providing a minimally-invasive treatment 
option with great therapeutic benefit. 
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